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Abstract
Matthew Sydor, Ph.D., Spring 2021
Mechanisms of Engineered Nano-material Induced membrane Disruption and Lysosomal
Membrane Permeability
Chairperson: Andrij Holian, Ph.D.
Engineered nano-materials (ENM), which have at least one dimension less than 100 nm are an
emerging group of materials that are widely used in everyday products and workplaces. Because
of the wide variety of ENM and their use in today’s society, there is a concern for the impacts of
ENM on human health following exposure. While humans could be exposed to ENM through
various routes, there is significant concern for inhalation of ENM due to their size and ease of
aerosolization. Studies have reported that ENM can deposit into the lungs, particularly in the
alveoli, where resident macrophages can encounter and phagocytose these materials. An event
known as phagolysosomal membrane permeability (LMP) caused by ENM in macrophages has
been shown to trigger NLRP3 inflammasome formation and inflammatory cytokine release, which
could lead to the development of chronic inflammatory diseases. It is predicted that LMP is a key
step in this inflammatory response and that a mechanistic understanding of this process is
important for the design of safer ENM and potential therapeutics for ENM-exposed individuals.
Here, two of the most commonly used ENM, titanium dioxide (TiO2) and zinc oxide (ZnO), were
selected for testing their ability to cause changes in membrane properties leading to LMP.
Crystalline silica was included because it is well known in its ability to cause LMP and
inflammatory diseases. Lipid membrane systems, such as liposomes and human red blood cells
(RBC), were used to model lysosomes of macrophages, in order to determine how ENM disrupt
lipid membranes and cause permeability. Spectroscopic techniques were used to demonstrate that
TiO2, ZnO, and silica interact with lipid membranes and cause changes to membrane order, most
notably an increase in lipid order, which lead to membrane permeability of small molecules in
these model systems. The ability of these materials to trigger LMP and NLRP3 inflammasome
formation in macrophage-like THP-1 cells was also investigated. Increased cell death and
inflammasome formation was observed upon treatment with these materials, indicating that LMP
is occurring, which precedes NLRP3 inflammasome formation and cytokine release. Together,
these data indicate that the ENM and silica tested can interact with and change the order of lipid
membranes. This change to order influences membrane permeability and could be a mechanism
of LMP in macrophages.
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Chapter 1
Introduction
1.1 Engineered Nano-materials
According to the National Institute of Environmental Health Sciences, engineered nano-materials
(ENM) have at least one dimension less than 100 nm and designed by humans for a specific
purpose. ENM are encompassed by the field of nanotechnology, which has and is seeing
significant growth. In 2000, the United States started the National Nanotechnology Initiative
(NNI), which allocates funding for research and development of nano-materials [1]. Since 2015,
there are thousands of consumer products that contain ENM [2]. Because of the broad definition
of ENM, there are a wide variety of ENM that differ in type, geometry, and composition. This
wide variety of ENM makes it difficult to accurately predict biological outcomes indicating a need
to develop novel screening procedures to improve potential adverse health outcomes.

1.1.1 Types and Uses of Engineered Nano-materials
While there are many possible types of ENM there are several main categories and use cases for
ENM. One category are metal and metal oxide ENM. Metal oxides are some of the most widely
used ENM in everyday products. For example, titanium dioxide (TiO2) and zinc oxide (ZnO) are
used in many types of sunscreens and cosmetics due to their color and UV reflective properties
[3]. Pure metal ENM such as silver have other uses such as antimicrobial or cancer therapeutic
agents [4,5]. Pure gold nanospheres also have a wide variety of applications. Because gold is
electron dense, nanosized gold has uses in imaging for electron microscopy [6]. Also, gold ENM
have been used in various biomedical applications including targeted cancer therapy, in which gold
1

ENM produce heat killing cancer cells after being triggered by infrared light [6,7]. If gold ENM
are smaller than 2 nm, they become much more toxic to cells, and can even enter the nucleus.
These smaller gold ENM have applications in therapies to produce targeted cell death [7,8].

Another category of ENM are carbon-based materials. These ENM have a variety of geometries
with fullerenes having a spherical shape, carbon nano-tubes being cylindrical, and graphene
materials being two-dimensional. Fullerenes, in particular, C60 have the ability to disrupt viral
replication, making them candidates for anti-viral treatments including HIV infection [9]. Carbonnanotubes are often used in products as stiff fibers to provide support and strength [10]. Many
products such as tennis rackets, hockey sticks, and bicycle frames utilize carbon nano-tubes
because of the need for durability, while also maintaining light weight. Lastly, graphene sheets are
used in various types of batteries, where they offer better charge capacity and life-span than
alternatives [10].

In recent years, the use of semiconductor ENM has emerged. In particular, quantum dots, such as
cadmium sulfate, are very popular semiconductor ENM, which have a variety of uses. When these
materials are excited with ultra violet light, they can emit light at a particular wavelength [11].
Because of this physical property, quantum dots can be tuned such that the material emits light at
a particular wavelength, allowing for these materials to function in the LED screens of electronic
devices. Quantum dots also have low toxicity and can be used in biomedical applications. For
example, they can be used to detect and image certain types of cancers because of their ability to
emit light at a detectable wavelength [11].
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Like the previously described materials, silica nanomaterials have a variety of different uses. For
example, a particular type of silica ENM is mesoporous silica. These particles are spherical in
nature with pores that can be used to store drugs for delivery in biomedical applications. This is
particularly helpful in promoting the controlled release of hydrophobic drugs that would otherwise
be difficult to deliver to specific targets [12,13]. Silica ENM have also been developed to aid in
reducing environmental pollutants, such as lead. Charged silica ENM have been shown to bind
lead from atmospheric sources and facilitate its purification [14]. This has an application for
workplace environments with heavy metal pollution.

Dendrimer or polymer ENM have many applications in the biomedical field. These materials
typically are spherical with an inner core connected to an outer core of branched molecules. The
outer core can be modified to enhance targeting to a specific organ, as well as, reduce the amount
of toxicity and aid in elimination from the body [15]. In cancer research PAMAM dendrimer ENM
were demonstrated to target to the lungs with minimal toxicity to normal cells, but were able to
deliver siRNA treatments to cancer cells in the lungs. Another example is when dendrimer ENM
were used to reduce breast cancer cell metastasis. By inhibiting a chemoattractant, breast cancer
metastasis to other tissues such as the lung and bone could be reduced [16].

1.2 Inhalation of Engineered Nano-materials

Humans can be exposed to ENM through several routes of exposure including oral, dermal, and
inhalation. Due to the fine nature of ENM (<100 nm), they are easily aerosolized, making the latter
route of exposure the greatest concern for humans [17–19]. The size of these particles will
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determine where they can deposit into the lungs. Particles suspended in the air is not a new concept,
and these particles can be inhaled by humans. There are two main classifications of particulate
matter, which are PM10 and PM2.5, which are smaller than 10 and 2.5 microns, respectively. PM10
can reach the nose and upper airways, while PM2.5 can deposit in the terminal bronchioles and
alveoli [20]. Because ENM are much smaller than PM2.5, the deposition is expected to be higher
and deeper in the lungs than PM2.5 with ENM reaching the alveolar space, where gas exchange
into the blood stream occurs. Inhaled ENM, can deposit into the lungs, as shown in experimental
studies with animals. In one study, carbon nanotubes were seen to deposit into the lungs of mice
and cause lung fibrosis [21,22]. The hydrophobicity of carbon nanotubes can also influence the
amount of inflammation and lung injury, where carboxylation on the surface of the carbon
nanotubes reduced these effects in vivo [23]. In another study with mice, amorphous silica ENM
were instilled into the lungs of mice, where they were seen to have reached the alveoli [24].

The ability of these ENM to deposit in the lungs causes concern for the development of chronic
inflammatory lung diseases in exposed individuals. While ENM-induced lung disease in humans
is not widely documented, exposures to other particulates, such as micron-sized crystalline silica
has been known for decades. Exposure to crystalline silica has been observed to trigger chronic
silicosis about 10-20 years after exposure [25]. Silicotic nodules, which contain collagen and silica
containing macrophages begin to form in the lungs and can reach 3-mm in diameter [25,26].
Widespread formation of silicotic nodules can result in progressive massive fibrosis, which
includes severe scarring and stiffening of the lungs [27,28] Consequences of pulmonary fibrosis
include difficulty breathing and cardiovascular complications; silica exposure can lead to systemic
autoimmune diseases, and even lung cancer [29].
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Silica-induced inflammation is thought to be triggered by innate immune cells called macrophages.
There are macrophages that reside in the alveoli that are called alveolar macrophages (AM). These
cells are phagocytic and will engulf particles that they come into contact with as part of their innate
immune function. After phagocytosis, the particles may not be degraded by the macrophage, and
can cause macrophage cell death or and development of an inflammatory response [30,31]. An
extensive body of literature suggest there are similarities between how AM interact with silica and
ENM.

1.3 Macrophages and Engineered Nano-materials

There are similarities between exposure to silica and ENM, with reports demonstrating the role of
macrophages in encountering ENM and subsequently triggering an inflammatory response. ENM
that reach the alveolar space can be phagocytosed by the resident AM. Several key steps occur
after phagocytosis of ENM or particulates that contribute to cell death in macrophages and
inflammation. Following phagocytosis, ENM are encapsulated in vesicles knows as phagosomes.
Eventually phagosomes will fuse with lysosomes, forming phagolysosomes [32–34]. The purpose
of phagolysosomes is to degrade biomolecules contained within them. However, phagocytosed
ENM or particulates are not broken down well or even at all. Eventually, an event known as
phagolysosomal membrane permeability (LMP) can happen, in which the enclosed ENM lead to
disruption of the phagolysosome, following potassium influx and the leakage of phagolysosomal
contents into the cytosol, including degradative enzymes such as cathepsins [35,36]. LMP can
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result in a few subsequent events that affect the macrophage. For example, LMP has been reported
to cause increased reactive oxygen species in the cytosol, along with damage to the mitochondria.
These features of LMP can lead to cell death through necrosis or apoptosis [33–35].

Another important event downstream of LMP is the formation of the nod-like pyrin domain
containing 3 inflammasome (NLRP3). The NLRP3 inflammasome is a protein complex that
functions in the processing of inflammatory cytokines such as IL-1ß and IL-18. The NLRP3
inflammasome cleaves caspase-1 to its active form, which in turn cleaves pro-IL-1ß and pro-IL18 to their respective active forms for secretion [37–39]. In order for the NLRP3 inflammasome
to form and cytokines to be released, transcription of these proteins are necessary. The transcription
factor, NF-kB promotes transcription of the genes for the inflammasome and the cytokines proIL-1ß and pro-IL-18 [40,41]. In macrophages, NF-kB can be activated by pattern recognition
receptor (PRR) signaling or more specifically toll-like receptor (TLR) signaling [41–43]. An
example of TLR signaling and NF-kB activation is when lipopolysaccharide (LPS), a component
bacterial cell walls, activates TLR-4 [44,45]. Another example of TLR activation is by high
mobility group box 1 (HMBG1) protein in what is termed “sterile inflammation” [46]. HMGB1
can be released from macrophages and other damaged cells during inflammation and has been
reported to activate TLR4 and NF-kB [35,47].

Another downstream event of LMP in macrophages is that of pyroptosis. Like apoptosis,
pyroptosis is a form of programmed cell death, which involves proteins forming a pore in the
plasma membrane and eventual cytosolic leakage. The formation of inflammasomes, along with
activation of pore forming Gasdermin proteins are hallmarks of pyroptosis [48–50]. This cytosolic
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leakage can include things like the cytokines IL-1ß and IL-18, as well as, other proteins such as
HMGB1, which serve as damage associated molecular patterns that maintain the inflammatory
response [51,52]. There are several types of inflammasomes, which sense with a pattern
recognition receptor (PRR) and respond to different signals withing the cell such as bacterial
components, double stranded DNA, and pathogen/damage associated molecular patterns (PAMP
and DAMP), in the case of NLRP3 [49,53]. After stimulation of the particular PRR, inflammasome
formation proceeds and recruits procaspase-1, which is then cleaved into its active form of caspase1 [48–50]. Caspases and in particular, caspase-1 can cleave the pore forming Gasdermin family of
proteins [48,54]. Most notably in macrophages, caspase-1 can cleave the Gasdermin D (GSDMD)
pore forming domain from the repressor domain and induce Gasdermin mediated plasma
membrane pore formation, resulting in cell lysis and release of inflammatory molecules [48,55,56].

There is another means of inducing pyroptosis, which is described as the non-canonical pathway.
This process is mediated by caspases-4/5 in humans and caspase-11 in mice [48,49,55,57,58]. In
this scenario, caspases-4/5/11 can directly bind to LPS from bacteria in the cytosol and become
activated. Activated caspase-4/5/11 can cleave Gasdermin D for plasma membrane pore formation
[55,57,58]. Gasdermin D pore formation can result in potassium efflux from the cell, which
induces the NLRP3 inflammasome and procaspase-1 activation, which in turn processes IL-1ß and
IL-18 to their mature forms for release from the cell [48,59,60].

ENM have been implicated in stimulating pyroptosis in macrophages. Carbon black and iron oxide
ENM-treated macrophages have been observed to undergo pyroptosis. Carbon black treatment was
shown to activate caspase-1 mediated pyroptosis, which was blocked by inhibiting caspase-1 or
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using a direct pyroptosis inhibitor [61]. Because caspase-1 is involved in inducing pyroptosis,
activation of the NLRP3 inflammasome can be an important event in determining whether a
macrophage will undergo pyroptosis. Another study using iron oxide ENM demonstrated that
NLRP3 and caspase-1 activation resulted in proteolytic cleavage of Gasdermin D, which resulted
in plasma membrane pore formation, cytokine release, and pyroptosis [62].

The molecular events, which include LMP, inflammasome activation, and Gasdermin pore
formation, are important in understanding particulate-induced inflammation and present potential
targets for treatments or therapeutics for exposed individuals. Since the intracellular damage
caused by LMP triggers these downstream events, it is thought to be the key step in particleinduced inflammation in macrophages. A diagram illustrating the pathway described above is
shown in Figure 1.

Figure 1: (Adapted from Bunderson-Schelvan et al., 2016)
Consequences of Lysosome Membrane Permeabilization.
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1.4 Lysosomal Membrane Permeability and Cholesterol
Lysosomes contain an acidic environment with degradative enzymes, which function to break
down various types of biomolecules. Therefore, leakage or permeability of the lysosome could be
dangerous for the cell, as described above. There are a few things that can cause LMP besides
particulates, such as lysosomotropic detergents and bacterial toxins. Lysosomotropic detergents
are molecules that are weakly basic with long hydrophobic tails. After entering the lysosome, they
will become protonated and insert in the lysosomal membrane until a high concentration is reached
and permeability results [63]. On the other hand, some bacterial toxins such as pneumolysin from
Streptococcus pneumoniae, can bind to cholesterol domains in the lysosome and form a pore,
resulting in apoptotic cell death in macrophages [64]. Particulates such as silica or ENM have also
been implicated in causing LMP. As previously mentioned, when particles are phagocytosed by
macrophages, they will accumulate within phagolysosomes. Because of the acidic environment
and hydrolytic enzymes in the lysosome, any lipid/protein corona on the particles will be degraded
allowing for bare particles to be present in the lysosome. From there, what happens next is less
clear.

There have been several ways in which LMP has been detected. The use of the lysosomotropic
probe, acridine orange, has been used to detect lysosomal leakage or rupture. Acridine orange
accumulates in lysosomes, and senses changes in pH by a shift in the probe’s fluorescence. When
LMP is initiated, the lysosomal pH rises, and so a green fluorescence can be detected, indicating
LMP. This method has been used to study LMP caused by a variety of triggers such as apoptotic
stimuli or ENM [65–67]. LMP has also been observed by detecting the leakage of fluorescent
dextran molecules from inside the lysosome out to the cytosol. This was done in studies that
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detected leakage of dextrans from the lysosome into the cytosol following LMP initiated by anticancer drugs [68,69]. Additionally, LMP has also been measured by detecting the activity of
cathepsins in the cytosol of cells undergoing LMP. Cathepsins are enzymes located in the
lysosome, and such their presence in the cytosol is indicative of lysosomal leakage. Cytosolic
cathepsin activity can be detected by incubating cell lysates with a fluorescently conjugated
substrate, which allows for quantification of LMP based upon the cytosolic activity of particular
cathepsins or lysosomal enzymes. This method has been used to quantify LMP induced by silica
and ENM in various studies [35,70,71].

It is proposed that these bare particles can interact with the lysosomal membrane in some way that
results in permeability. For example, accumulation of cholesterol in the lysosome has been shown
to reduce the amount of LMP and potentially IL-1ß release [72,73]. The amphiphilic drug,
U18666A blocks cholesterol trafficking out of the lysosome, causing increased lysosomal
cholesterol levels. Human fibroblasts treated with the lysosomotropic agent MSDH had increased
levels of apoptotic cell death along with the presence of cathepsins in the cytosol. Administration
of U18666A showed decreased levels of apoptotic cell death, as well as cathepsins in the cytosol
[72,73]. Furthermore, increased lysosomal cholesterol has been shown to block oxidant-induced
permeabilization of the lysosomal membrane. Again, treatment with U18666A, along with
imipramine and clozapine increased lysosomal cholesterol detected by filipin staining [74]. This
increase in cholesterol reduced the ability of photo-activated NPe6 to induce LMP. Taken together,
these reports from the literature indicate that the levels of lysosomal cholesterol play a critical role
in the stability of the vesicle and its permeability. Since cholesterol is known to mediate membrane
structure, fluidity, and permeability, it is important to understand how it can change the properties
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of lysosomes, as well as, lessen the ENM or particulate-induced membrane disruption that results
in leakage.

1.5 Lipid Membrane Order
Cellular lipid membranes mainly contain phospholipids, sterols, and proteins. All of these
components function to provide structure, a barrier of protection for the cell, and channels for
allowing certain materials to pass in or out of the cell [75,76]. Due to this heterogenous
composition of membranes, they can vary in specific properties that govern their function. Two of
the most relevant properties are lipid fluidity and order. Membrane fluidity is commonly defined
as the ability for lipids within a membrane to diffuse laterally. This can be influenced by factors
such as the composition of the membrane, temperature, and the packing of the lipids in the
membrane, which relates to lipid order [77,78]. Lipid order refers more to the packing of lipids
within a membrane, where a higher degree of lipid order represents a more tightly packed
membrane [79]. These characteristics of membrane fluidity and order are important factors when
considering the biological function of cell membranes and proteins that are membrane bound or
interact with membranes. In particular, changes in membrane fluidity have been shown to affect
the function of the sodium pump and osmotic stability of human erythrocytes [76,80,81]. Packing
of lipid membranes also influences particular proteins such as mechanosensitive ion channels in
E. coli. These proteins transport ions across membranes in response to how much stress is applied
to the protein from lipid packing [82,83].

Another characteristic of lipid membranes that influences their order is the presence of lipid rafts.
These lipid rafts are smaller portions of the lipid membrane called microdomains, which often
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contain proteins and higher amounts of cholesterol and sphingolipids. Because of the unique
composition of lipid rafts, they facilitate the function of certain proteins that are sensitive to lipid
order, as well as, protein-protein interactions within one lipid raft domain [76,77]. The human
brain contains a relatively high amount of cholesterol, and consequently contains lipid rafts that
regulate various processes such as neuronal adhesion, neuronal cell signaling, and axon guidance
[84]. Cholesterol has been shown to influence not only the order in membranes, but also the
structure and permeability to small components such as ions [85]. Because of this, cholesterol has
been proposed to be a regulator when membrane permeability events such as LMP occur [72,73].
Cholesterol is also involved in various diseases, such as Niemann Pick Disease, so its presence
and role in lipid membranes must recognized, in order to better understand some of these diseases.

One way in which membrane composition, order, and fluidity is studied is by examining lipid
membrane model systems. These systems can range from intact erythrocytes, small unilamellar
vesicles (SUV, 10-100 nm), giant unilamellar vesicles (GUV, 1+ µm), and even bilayers on solid
supports [86]. The advantage of using these systems is that they allow for complete control over
the composition of the membrane and are particularly important for studying the biophysical
properties of the membrane and what influences them. Model liposomes, SUV and GUV, are
useful when studying different phases of the membrane such as liquid disordered (Ld) or liquid
ordered (Lo) phase. This can be helpful in understanding the formation of lipid rafts and where
molecules will partition [87,88]. SUV have also been utilized to better investigate the interaction
between ENM and lipid membranes, similar to what happens in the phagolysosome of
macrophages prior to LMP. These studies have looked at the adsorption of ENM to liposomes for
the purpose of determining which ENM interact with a certain type of lipid [89,90]. The use of
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lipid model systems can bridge the gap of knowledge in comprehending what properties of ENM
and phospholipids dictate an interaction between the two and the resulting changes to membrane
order.

1.6 Aims
1.6.1 Aim 1
The first aim of this project was to determine the effects of different ENM (TiO2 and ZnO) and
silica on model membrane systems. Model membranes were used because they are easily
manipulatable and allow for probing the interaction between particle and membrane, which is
difficult in macrophages. Human RBC and 100-nm liposomes were used as model systems that
simulated what may happen between ENM/silica and the phagolysosomal membrane in
macrophages. Particle-induced changes to membrane properties were detected from fluorescence
emissions of the lipophilic probe, Di-4-ANEPPDHQ. Liposomes composed of either
phosphatidylcholine or phosphatidylserine were treated with TiO2, ZnO, or silica with subsequent
time-resolved anisotropy measurements taken. These measurements describe the rotational
freedom, or cone angle of Di-4-ANEPPDHQ in the membrane. All three materials increased lipid
order in different phospholipids. To analyze changes to human RBC membranes, fluorescence
lifetime imaging microscopy (FLIM) measurements were taken. Increased lipid order was caused
by TiO2 and silica, while ZnO decreased lipid order. In order assess the ability of nearly free
silanols (NFS) on the surface of different quartz materials, phosphatidylcholine and
phosphatidylserine liposomes of varying sizes were treated with different quartz materials with
time-resolved anisotropy measurements. Changes in lipid order were correlated with hemolysis
along with cell death and cytokine release in macrophages. Most materials increased the lipid order
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of phosphatidylcholine, with the materials causing the largest change in lipid order also causing
the most hemolysis and bioactivity in macrophages. This aim demonstrates that particle-membrane
interactions can occur with changes to membrane order that can lead to permeability, which may
be an explanation for the mechanisms of LMP in alveolar macrophages.

1.6.2 Aim 2
The second aim on this project was to investigate the ability of ENM to cause LMP and
inflammasome formation in in vitro on a time scale and dose response manner. Macrophage-like
THP-1 cells were used as a model for alveolar macrophages. In particular, THP-1 cells stably
expressing yellow fluorescent protein (YFP) tagged apoptosis-associated speck-like protein (ASC)
were used for a means of detecting and quantifying inflammasome formation that happens
downstream of LMP. These cells were treated with either TiO2 or ZnO for a time period of 4 or
24 hours prior to imaging on an iCys laser scanning cytometer, in order to quantitate
inflammasome formation. Both materials caused a dose dependent increase of inflammasome
formation at 4 hours with the largest increase in inflammasome formation being at 24 hours. ZnO
caused increased levels of cell death and was a more potent inflammasome activator compared to
TiO2. The activation of GSDMD was analyzed in these cells as an indication of pyroptosis caused
by ENM treatment. Western blots for GSDMD were done, showing that upon ZnO treatment, there
was increased GSMDM cleavage, causing increased pyroptotic activity in the cells. This work
shows the ability of ENM to cause LMP, and subsequent steps in the inflammatory pathway, which
include NLRP3 inflammasome formation, along with GSDMD pore formation in the plasma
membrane, which has been associated with cytokine release [49,57–59].
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Abstract

Engineered Nano-materials (ENM) have been reported to affect lipid membrane permeability in
cell models, but a mechanistic understanding of how these materials interact with biological
membranes has not been described. To assess mechanisms of permeability, liposomes composed
of DOPC, DOPS, or POPC, with or without cholesterol, were used as model membranes for
measuring ENM-induced changes to lipid order to improve our understanding of ENM effects on
membrane permeability. Liposomes were treated with either titanium dioxide (TiO2) or zinc oxide
(ZnO) ENM, and changes to lipid order were measured by time-resolved fluorescence anisotropy
of a lipophilic probe, Di-4-ANEPPDHQ. Both ENM increased lipid order in two lipid models
differing in headgroup charge. TiO2 increased lipid order of POPC liposomes (neutral charge),
while ZnO acted primarily on DOPS liposomes (negative charge). Addition of cholesterol to these
models significantly increased lipid order while it attenuated ENM-induced changes to lipid order.
To assess the ability of ENM to induce membrane permeability, liposomes composed of the above
lipids were assayed for membrane permeability by calcein leakage in response to ENM. Both ENM
caused a dose-dependent increase in permeability in all liposome models tested, and the addition
of cholesterol to the liposome models neither blocked nor reduced calcein leakage. Together, these
experiments show that ENM increases permeability of small molecules (calcein) from model
liposomes, and that the magnitude of the effect of ENM on lipid order depends on ENM surface
charge, lipid head group charge and the presence of cholesterol in the membrane.
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Introduction

The term engineered nano-material (ENM) encompasses a wide variety of materials, the use of
which is becoming more prevalent in today’s consumer products. According to the Project on
Emerging Nanotechnologies, there are over 1800 consumer products that contain ENM [1]. With
this increased use of ENM, the concern for human exposure to such materials has increased. One
of the major routes of ENM exposure is by inhalation [2,3]. Inhaled ENM deposit on the epithelial
surfaces of the lungs and would be expected to be cleared by alveolar macrophages (AM), innate
immune cells of the lung that have been observed to phagocytose these materials [4-6]. Following
phagocytosis by AM, the ENM are eventually encapsulated within phagolysosomes. We have
reported, as well as others, that ENM can induce lysosomal membrane permeability (LMP) in
cells, thereby causing the release of lysosomal degradative enzymes into the cytosol7-9. Following
the release of lysosomal enzymes, mitochondrial damage can occur, along with assembly of the
NLRP3 inflammasome [10,11]. The NLRP3 inflammasome is responsible for activating caspase1, which cleaves IL-1ß and IL-18 into their mature forms for secretion [12-14]. Specifically,
elevated levels of IL-1ß have been implicated in various states of inflammation [15-17].

Current evidence supports the notion that LMP is the key step in this inflammatory pathway and
occurs prior to inflammasome activation and cytokine release [18]. The ability to understand and
prevent LMP would present options for mitigating the adverse health effects of the ENM-induced
inflammation. Although, much is known about how ENM cause inflammation, little is known
about what causes LMP to occur and what effects ENM have on lipid membranes, resulting in
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LMP. In order to bridge this gap of knowledge, a basic understanding of how ENM affect lipid
membranes is necessary. Here, ENM-lipid membrane interactions were studied by treating
unilamellar liposomes of various phospholipid compositions (DOPC, POPC, and DOPS) with two
common ENM, titanium dioxide (TiO2) or zinc oxide (ZnO), which are 24 and 20 nm in size,
respectively. These well characterized materials were selected because of their similarity in type
(metal oxide), size, and their ability to be suspended and dispersed in aqueous buffers without the
need of a surfactant but differ in surface charge at neutral pH, where TiO2 has essentially zero
charge and ZnO has strong positive charge [19,20]. Both of these ENM have been reported to
cause LMP in vitro with ZnO being more bioactive than TiO2. At similar doses ZnO causes greater
LMP than TiO2 in macrophages [8,21]. In our work, both materials caused increased lipid order
and an increase in permeability to calcein. We propose that an interaction between the ENM and
liposomes would cause changes to the lipid order/disorder of the membrane.

Methods

Materials
The following lipids were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL): 1-palmitoyl2-oleoyl-glycero-3-phosphocholine

(POPC)

(Cat#

850475),

1,2-dioleoyl-sn-glycero-3-

phosphocholine (DOPC) (Cat# 850375), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium
salt) (DOPS) (Cat# 840035), and cholesterol (ovine) (Cat# 700000). 1-[2-Hydroxy-3-(N,N-dimethyl-N-hydroxyethyl)ammoniopropyl]-4-[β-[2-(di-n-butylamino)-6-napthyl] vinyl]pyridinium
dibromide (Di-4-ANEPPDHQ) (Cat# D36802) was purchased from ThermoFisher (Waltham,
MA). Titanium dioxide P225 (81% anatase, 19% rutile) and zinc oxide were obtained from Evonik
(Parsippany, NJ) and Meliorum Technologies Inc. (Rochester, NY), respectively.
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Liposome Preparation
All phospholipids were purchased from Avanti Polar Lipids, Inc. as chloroform solutions.
Cholesterol was dissolved in HPLC grade B&J Chloroform, containing amylene and 1% ethanol
preservatives at 5 mg/ml. Appropriate concentrations were dried for at least one hour under a
stream of nitrogen gas. The lipid films were then hydrated in a 50 mM tris (pH 7.4), 150 mM NaCl
buffer (TBS). Lipids were then sonicated in a bath sonicator for 10 minutes with vortexing once
every minute. Liposomes, either 100 or 400 nm in diameter, were generated using an Avanti Polar
Lipids, Inc. mini extruder heated 10°C above the phase transition temperature of the lipid.
Time-resolved Anisotropy Decay Measurements
To perform time-resolved anisotropy measurements, 100-nm liposomes were used. For each
sample, 0.85 mg of lipid was used to form liposomes as described above. ENM stock suspensions
were prepared at 1 mg/ml in the buffer listed above and sonicated for 2 min in a Qsonica
(Newtown, CT) Q500 sonicator. ENM were then mixed with the liposome suspension at the
desired concentration and placed in a tube rotator at 37°C for 2 hours. Di-4-ANEPPDHQ was
dissolved in spectral grade DMSO and added to the liposome samples at a concentration of 400
nM (final DMSO concentration of <1%). The dye was allowed to incubate at room temperature
with the liposomes for 15 minutes before data acquisition. Fluorescence measurements were
collected using a custom-built fluorimeter (Quantum Northwest, Liberty Lake, WA) as previously
described [22]. The probe, Di-4-ANEPPDHQ was excited by a 470-nm pulsed diode laser (LDHP-C-470; PicoQuant, Berlin GmbH). Fluorescence emissions were isolated by a 500-nm longpass
filter (Chroma, Bellows Falls VT) and detected using an Edinburgh Instruments (Livingston, UK)
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photomultiplier tube (H10720–01). Measurements were taken at 18.5 ± 0.02°C. Anisotropy decay
measurements were analyzed using FluoFit v4.6.6 (PicoQuant, Berlin GmbH).
Liposome Lysis Assay
Liposomes that were 400 nm in diameter were prepared as described above. In this assay, the
hydration of the lipid film was performed with 50 mM calcein solution in TBS. The calcein
(ThermoFisher, Waltham, MA Cat# C481) solution was made by mixing calcein powder in TBS
with stirring, low heat, and adjusting the pH to 7.4 with NaOH. The liposomes were then vortexed
and extruded with a 400 nm filter. Free calcein was separated from the liposomes by gel filtration
of 1-ml liposome samples using a 10-ml column of Sepharose cl-4b (GE Life Sciences, Pittsburgh,
PA) with TBS as the eluent. The eluted samples were diluted16-fold in TBS and stored at 4°C for
use within 48 hours. The appropriate amount of ENM was added to each tube, followed by
incubation at 37°C with tumbling for 2 hours. All fluorescence intensity measurements were taken
on a SpectraMax M4 (Molecular Devices, San Jose, CA) with excitation at 490 nm and emission
at 520 nm. A background fluorescence measurement was taken immediately after particles were
added. Another was taken after the 2-hour incubation, and finally a total fluorescence measurement
was acquired after adding 10 µl of 1% Triton-x to each sample. The leakage of each sample was
calculated as a percent by using equation #2
Statistical Analyses
Two-tailed, unpaired t-tests to compare two means, along with one-way ANOVA with Dunnett
post-test, were performed using Statistica 176 (TIBCO Software, Inc.). P-values < 0.05 were
determined to be statistically significant.
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Results

To elucidate changes to the order of the model membranes, time-resolved fluorescence anisotropy
measurements were utilized. Time-resolved anisotropy directly reports the rate of depolarization
of the emission of fluorophores incorporated in lipid membranes; the degree of depolarization is a
measure of the lipid order. In these studies, a lipophilic fluorescence probe, Di-4-ANEPPDHQ,
was used to report changes in the lipid order of model membranes as a result of ENM-liposome
interaction. Di-4-ANEPPDHQ is solvatochromic and incorporates into both the ordered and
disordered phases of lipid membranes. Previous characterization work with this probe by our
laboratory, and others, has demonstrated that its spectra and anisotropy are sensitive to the local
environment in the membrane. Thus, Di-4-ANEPPDHQ is suitable for detecting changes to lipid
order/disorder in cells and model systems [23-27]. Time-resolved anisotropy parameters were
determined by equation #1 (see appendix) [28]. Following acquisition, the data were analyzed
using the wobble-in-a-cone model, equation #2, appendix. The cone-angle value, θ, can be used to
describe the wobble and constraint of the fluorescence probe in the lipid bilayer [29,30]. Thus, θ
indicates the lipid order around the probe, Di-4-ANEPPDHQ. The lipids selected for this study,
shown in Table 1, were chosen based on the working hypothesis that if ENM disrupt lipid
membranes, the composition of phospholipid headgroups and tail-groups will play a role in
whether or not this disruption takes place and the extent of the effects. The phospholipids used in
these studies had two types of headgroups: phosphatidylcholine (neutral zwitterion) or
phosphatidylserine (negatively charged). The length and saturation the acyl chains of the
phospholipids were either 16:0-18:1 or 18:1.
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Table 1. Phospholipids Used for Model Liposomes.
Overall
Lipid

Structure
Charge

POPC

Neutral

DOPC

Neutral

DOPS

-1

These lipids were chosen because both phosphtidylcholine and phosphatidylserine are biologically
relevant and prevalent in the lysosomes of mammalian cells [31]. Cholesterol is one of the most
abundant lipids in mammalian cells, and it has been implicated in modifying the lipid order of the
membrane for appropriate cellular function [30]. In particular, cholesterol has been observed to
increase the favorable packing of the acyl chains in model phosphatidylcholine systems [32,33].
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Therefore, we also examined how cholesterol would affect the action of ENM on the model
membranes.

In order to assess the impact of cholesterol on the model membranes in this study, cholesterol was
incorporated into DOPC, DOPS, and POPC 100-nm liposomes. Figure 1 displays time-resolved
anisotropy data for these liposomes, with or without cholesterol, at an equal mass ratio. In this
way, two systems were generated with definitive differences in lipid order and cholesterol content
for determining how the change in membrane properties affects ENM-induced disruption. The

*

*

*

Figure 1: Time-resolved Anisotropy of Model Liposomes with and without Cholesterol. Anisotropy data is displayed in
degrees of the wobble-in-a-cone angle. Unpaired t-tests were used to compare untreated liposomes to ENM treated. *
indicates p<0.05. n=3-5

addition of cholesterol to all three model systems resulted in a significant reduction in the cone
angle of the probe Di-4ANEPPDHQ with the largest change occurring in POPC liposomes. The
data is consistent with the prediction that cholesterol can cause an increase in lipid order and
packing in model membranes and cells [24,34].

To better understand how the phospholipid headgroups impact on ENM-induced membrane
disruption, DOPC, DOPS, and POPC 100-nm liposomes, with or without cholesterol, were treated
with 100 µg/ml TiO2 or ZnO for two hours prior to time-resolved anisotropy measurements. To
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measure how changes to lipid order affect membrane permeability, an assay was employed that
utilized the self-quenching properties of the small (MW 622.54) fluorescent molecule, calcein
[35,36]. When released from permeabilized liposomes, dilution reverses the self-quenching and
the fluorescence intensity increases. The assay involved loading 400-nm liposomes with 50 mM
calcein solution and the excess calcein outside of the liposomes was removed by gel filtration;
membrane permeability caused by ENM was expected to result in an increase in calcein
fluorescence. The liposomes were diluted such that their total surface area was equal to the surface
area of the 100-nm liposomes in the anisotropy experiments. Consequently, the liposome to ENM
surface area ratio for both studies remained the same. The doses of ENM were 25 µg/ml and 100
µg/ml with 2-hour incubations at 37ºC with gentle mixing. The amount of leakage was calculated
as a percent, determined by equation #3, appendix. Lastly, to determine the effects of cholesterol
on liposome leakage, DOPC, POPC, and DOPS 400-nm liposomes were prepared in an equal mass
ratio of phospholipid to cholesterol, and the assay was performed as above.
Figure 2 displays anisotropy data in cone angle form and calcein leakage data for DOPC liposomes
treated with TiO2 or ZnO. Treatment with either particle did not produce a significant change in
the cone angle, but the high doses of TiO2 and ZnO both caused increased calcein leakage
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compared to control levels. In the case of DOPC-chol liposomes, TiO2 caused a decrease to the
cone angle. The same liposomes
*

showed an increase in leakage

*

caused by the ENM. However,
there was no statistical difference
after a one-way ANOVA with
Dunnett post-test was performed.
The p-values for the comparison

*

between the high doses of TiO2
and ZnO and the DOPC-chol
control were 0.086 and 0.11,
respectively.
The

results

of

the

DOPS

membrane model are displayed in
Figure 3. In contrast to its effect on
DOPC,

ZnO

produced

a

Figure 2: Time-resolved Anisotropy and Calcein Leakage of DOPC
Liposomes Treated with ENM. The doses of ENM was 100 µg/ml for 2
hours. Anisotropy data is displayed in degrees of the wobble-in-a-cone angle.
Calcein leakage for ENM exposures were at 25 and 100 µg/ml after 2 hours.
Percent leakage was calculated by using equation #3. Unpaired One-way
ANOVA with Dunnett post-test were used to compare untreated liposomes
to ENM treated. * indicates p<0.05. n=3

significant decrease in the cone
angle of DOPS liposomes (29.4%); TiO2 did not alter the cone angle significantly. These results
indicate that the negative charge of the DOPS headgroup could have a role in the interaction of
ZnO with DOPS and the resulting restriction of the membrane. DOPS leakage results were similar
to those of DOPC in that, again, the 100 µg/ml dose of both particles caused significant increases
in the percent leakage. ZnO increased order in membranes containing DOPS. However, with the
presence of cholesterol, the amount by which the cone angle decreased was attenuated. Since the
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DOPS and cholesterol mixture is inherently more ordered, the order induced by the ZnO was less.
Finally, DOPS-chol liposomes
were tested with both ENM,
and

there

was

*

*

*

significant

leakage at 100 µg/ml TiO2, as
well as, at the 25 and 100 µg/ml
doses of ZnO.
To determine if the length and
saturation of the acyl chains on

*
*

*

the lipids influenced the ENMliposome interactions, POPC
liposomes were exposed to
both ENM. The results in
Figure 4 demonstrate that TiO2
caused a significant decrease in

Figure 3: Time-resolved Anisotropy and Calcein Leakage of DOPS Liposomes
Treated with ENM. The doses of ENM was 100 µg/ml for 2 hours. Anisotropy
data is displayed in degrees of the wobble-in-a-cone angle. Calcein leakage for
ENM exposures were at 25 and 100 µg/ml after 2 hours. Percent leakage was
calculated by using equation #3. Unpaired One-way ANOVA with Dunnett
post-test were used to compare untreated liposomes to ENM treated. *
indicates p<0.05. n=3

the cone angle of POPC
liposomes, while ZnO did not
have a significant effect. These data indicate that TiO2 appears to interact with POPC, while ZnO
acts on DOPS liposomes. Similar to both DOPC and DOPS liposomes, the 100 µg/ml dose of
both ENM caused significant increases in the calcein leakage from POPC liposomes. The addition
of cholesterol to this model attenuated the change in cone angle but not the increase in membrane
permeability. The mean cone angle of POPC with TiO2 treatment decreased from 33.9º to 27.9º
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(Table appendix), while with the addition of cholesterol TiO2 treatment produced a decrease from
16.7º to 13.9º.

Discussion
In this study, two different assays
were used to determine the effect

*

*

*

of ENM-induced lipid membrane
disruption.

Time-resolved

anisotropy was used to determine
changes in lipid order of model
liposome systems. Treatment with
ENM

resulted

in

decreased

wobble-in-a-cone
representing

increased

*

*
*

angle,
lipid

packing (increased order) around
the probe, Di-4ANEPPDHQ. We
propose that these changes are a
result of ENM, when near or

Figure 4: Time-resolved Anisotropy and Calcein Leakage of POPC Liposomes
Treated with ENM. The doses of ENM was 100 µg/ml for 2 hours. Anisotropy
data is displayed in degrees of the wobble-in-a-cone angle. Calcein leakage for
ENM exposures were at 25 and 100 µg/ml after 2 hours. Percent leakage was
calculated by using equation #3. Unpaired One-way ANOVA with Dunnett
post-test were used to compare untreated liposomes to ENM treated. *
indicates p<0.05. n=3

interacting with the phospholipid
surface, restricting lipid motion.
This restriction, may cause a disruption in other regions of the membrane away from the ENM,
resulting in the calcein leakage. These data demonstrate that both ENM have a similar effect on
the different model lipid membranes examined in this study. However, an important finding is that
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the two ENM appear to interact with different headgroups. Phosphatidylcholine lipids seem to be
the most affected by TiO2 treatment with POPC and DOPC-chol cone angles being reduced,
indicating increased localized order in the membrane. ZnO treatment caused a significant reduction
in the cone angle of DOPS liposomes. Similar changes in anisotropy were caused by both ENM
with the difference being which lipids were affected.

Addition of cholesterol caused a marked reduction in the baseline cone angle of the model systems,
which is a result of cholesterol increasing lipid packing and thus increasing order. However,
addition of cholesterol did not completely abolish ENM-induced membrane disruption.
Cholesterol reduced the anisotropy change of both ZnO on DOPS-chol liposomes and TiO2 on
POPC-chol liposomes. ENM and cholesterol seem to have similar effects on membranes, resulting
in minimal reduction to ENM-increased membrane order by cholesterol. Nevertheless, the
decrease caused by cholesterol may be physiologically relevant and explain the protective effects
of increasing cholesterol in lysosomes by blocking LMP [37,38].

The calcein permeability assay was performed to measure ENM-induced lipid membrane
permeability to small molecules. All three model systems, DOPC, DOPS, and POPC,
demonstrated significant increases in calcein leakage in response to the high doses of ENM. These
results appear to be in contrast to the anisotropy data, which appear dependent both on lipid
headgroup charge and ENM type. It is possible that ENM affect all lipid models studied here. The
anisotropy reporter probes will likely be distributed uniformly in unperturbed liposomes. However,
interaction with ENM would be expected to affect the dynamics of those probes located in the
vicinity of ENM, and observable anisotropy changes would require enough ENM to be interacting
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with the liposomes at one time in order to measurably shift the now non-uniform distribution of
probes in the liposomes. Comparatively, the calcein permeability assay appears to be more
sensitive, as only a small disruption/pertubation is likely needed to cause leakage of calcein, which
can easily be detected by changes in fluorescence intensity. Among the calcein leakage results,
there were differences in control leakage levels, depending on the type of lipid. The DOPC and
POPC control levels were 33.2% and 28.1%, respectively and much higher than DOPS (7.8%).
This is likely due to high permeability of the calcein through the DOPC and POPC liposomal
membranes since it is a small molecule and the lipid headgroups have neutral charge. In
comparison, DOPS baseline leakage levels were much lower probably because of charge repulsion
between the negatively charged calcein (at pH 7.4) and the phosphatidylserine headgroup.

Conclusions
Previous publications have reported that ZnO is more bioactive and causes more LMP in
macrophages than TiO2. This prompted our interest to study more closely the mechanism of
membrane disruption between two ENM of similar size but with distinct differences in charge.
Both ENM caused calcein leakage from liposomes composed of lipids with headgroups having
either neutral or negative charge. Furthermore, the addition of cholesterol increased the order of
the model systems and attenuated ENM-induced membrane changes. However, cholesterol did not
have a large-scale effect on the amount of calcein leakage due to ENM. A potential explanation is
that calcein is a small molecule and the changes to lipid order caused by the cholesterol were not
sufficient to inhibit movement of this small molecule across the lipid bilayer. Additional
experiments will be necessary to measure the ability of ENM to cause release of larger
biomolecules, such as proteins of various sizes (viz., similar to lysosomal proteases), from different
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types of lipid vesicles. We anticipate that measurement of ENM-induced movement of proteins
across model lipid membranes may give further insight into the biological processes of LMP and
the kinds of ENM that can produce it.

Appendix: Supplementary Data
Time-resolved Anisotropy Theory and Equations
Equation#1
𝐼)) (𝑡) − 𝐼)+ (𝑡)
𝑟 (𝑡 ) =
𝐼)) (𝑡) + 2𝐼)+ (𝑡)
The anisotropy is given by the value, r. The total intensity is defined by the tern I(t), while the
vertical and horizontal emission decays are IVV and IVH, respectively.
Equation #2

/
𝑟0
1
𝑆 =
= 2 cos(𝜃) (1 + cos(𝜃))8
𝑟1
2
The order parameter, S, represents the order of a lipid membrane and is defined by the relationship
/

of r¥/r0. In a lipid membrane, the initial anisotropy is r0, while the residual anisotropy that the
fluorescence probe decays to is r¥. This relationship between r0 and r¥ can be used to determine a
range of motion of the fluorescence probe, or a wobble-in-a-cone angle, θ.
Equation #3
% Leakage = [(It – I0)/(Imax – I0)] * 100
The percent of calcein leakage was calculated by subtracting the background intensity, I0, from the
intensity after incubation (It) and the total intensity (Imax) upon complete lysis. Then It is divided
by Imax and multiplied by 100 to generate a percentage.
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Example of Anisotropy Decay Curves

VV:
Above is an example anisotropy decay for vertically (90º) polarized excitation with vertically
polarized emission.

VH:
Above is an example anisotropy decay for vertically (90º) polarized excitation with horizontally
(0º) polarized emission.
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Table 1: Mean Cone Angle Values
Lipids
DOPC
DOPC-chol
DOPS
DOPS-chol
POPC
POPC-chol

Treatment
Control
35.9 ± 1.6
20.6 ± 1.2
35.4 ± 1.4
20.6 ± 1.2
33.9 ± 1.6
16.7 ± 2.9

TiO2
36.2 ± 0.4
15.9 ± 1.5
32.9± 0.5
18.9 ± 1.5
27.9 ± 3.3
13.9 ± 3.9

ZnO
36.6 ± 4.9
18.5 ± 0.8
25.5 ± 2.3
17.9 ± 0.5
33.8 ± 2.1
15.9 ± 3.4

Listed in the table are mean cone angle values for triplicate experiments with the standard deviation
shown.

Graphical Abstract
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Abstract

With the use of engineered nano-materials (ENM) becoming more prevalent, it is essential to
determine potential human health impacts. Specifically, the effects on biological lipid
membranes will be important for determining molecular events that may contribute to both
toxicity and suitable biomedical applications. To better understand the mechanisms of ENMinduced hemolysis and membrane permeability, fluorescence lifetime imaging microscopy
(FLIM) was performed on human red blood cells (RBC) exposed to titanium dioxide ENM, zinc
oxide ENM, or micron-sized crystalline silica. In the FLIM images, changes in the intensityweighted fluorescence lifetime of the lipophilic fluorescence probe Di-4-ANEPPDHQ were used
to identify localized changes to membrane. Time-resolved fluorescence anisotropy and FLIM of
RBC treated with methyl-ß-cyclodextrin was performed to aid in interpreting how changes to
membrane order influence changes in the fluorescence lifetime of the probe. Treatment of RBC
with methyl-ß-cyclodextrin caused an increase in the wobble-in-a-cone angle and shorter
fluorescence lifetimes of di-4-ANEPPDHQ. Treatment of RBC with titanium dioxide caused a
significant increase in fluorescence lifetime compared to non-treated samples, indicating
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increased membrane order. Crystalline silica also increased the fluorescence lifetime compared
to control levels. In contrast, zinc oxide decreased the fluorescence lifetime, representing
decreased membrane order. However, treatment with soluble zinc sulfate resulted in no
significant change in fluorescence lifetime, indicating that the decrease in order of the RBC
membranes caused by zinc oxide ENM was not due to zinc ions formed during potential
dissolution of the nanoparticles. These results give insight into mechanisms for how these three
materials might disrupt RBC membranes and membranes of other cells. The results also provide
evidence for a direct correlation between the size, interaction-available surface area of the nanomaterial and cell membrane disruption.

Keywords: FLIM, fluorescence lifetime, engineered nano-material

Introduction
Engineered Nano-materials (ENM) encompass a wide variety of materials designed for specific
applications. They are defined as having one dimension that is less than 100 nm. They are used in
everyday products and industries such as electronics, cosmetics, paints, and even in biomedical
diagnostics and therapeutics [1-5]. With such a variety of uses, it is important to understand their
potential impacts toward human health. Due to the size and ease of aerosolization, there is a
concern for human inhalation of ENM [6,7]. During inhalation, ENM can make their way into the
alveoli and be encountered by alveolar macrophages [8-10]. Macrophages can phagocytose these
materials, and eventually release IL-1ß, which can trigger inflammation and potential chronic
disease [11-14]. It has been proposed that permeabilization of the phagolysosomal membrane
(LMP) is a key step in this inflammatory pathway, which can lead to NLRP3 inflammasome
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activation and IL-1ß release [15-19]. In particular, crystalline silica has been demonstrated to cause
pulmonary fibrosis and lung disease in humans along with LMP [14, 19]. There is less
documentation of ENM causing this effect in humans, however, it may follow a mechanism similar
to that of silica.

Another important consideration of the health effects of ENM is blood compatibility, in particular,
their negative impact on erythrocytes [20-23]. This concept has been tested on a variety of different
materials by a hemolysis assay [24-26]. Here, we investigated the mechanisms behind the ability
of 24-nm titanium dioxide (TiO2), 20-nm zinc oxide (ZnO), and ~2.0-µm crystalline silica to cause
membrane disruption of human red blood cells (RBC). All three of these materials have been
reported to cause varying levels of LMP in macrophages and hemolysis in RBC, with silica being
the highest, followed by ZnO and TiO2 [19, 27-29].

Fluorescence techniques have been employed previously to study the dynamic characteristics of
lipid membranes such as lipid order, also described as fluidity, as seen in the review cited here
[30]. In particular, solvatochromic fluorescence probes have been shown to report on the lipid
order in membranes [31-37]. To better understand mechanisms of how ENM or silica disrupt
membranes and cause permeability, time-resolved fluorescence lifetime imaging microscopy
(FLIM) of RBC membranes was performed. FLIM measures the fluorescence lifetime of a
fluorophore at each pixel scanned, thereby producing a heat-map style image containing the
intensity weighted average fluorescence lifetime at each pixel. This type of image can report
localized changes to fluorescence lifetime in a sample. In this work, FLIM was utilized to
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investigate the types of changes to membrane properties cause by ENM, which may contribute to
well-documented events such as hemolysis and LMP.

The intensity-weighted average lifetime of the lipophilic fluorescence probe, di-4-ANEPPDHQ,
was used to measure the order of the RBC membranes in response to ENM or silica treatment.
RBC were incubated for 4 hours with doses of particles ranging from 25-200 µg/ml and then were
imaged by FLIM. The intensity-weighted fluorescence lifetime was calculated for each region of
interest with multiple random fields averaged together to generate an experimental replicate. The
fluorescence lifetime of di-4-ANEPPDHQ increased following treatment with silica and TiO2,
indicating an increase in RBC membrane order. On the other hand, treatment with ZnO
significantly decreased the fluorescence lifetime, indicating decreased membrane order. These
results show that the interaction of RBC and particles cause a change in the membrane properties
of the RBC, and that these changes may be important when considering hemolysis and membrane
permeability.

Methods
Materials
Human red blood cells (CAT# IWB3ALS40ML) were from Innovative Research, Inc (Novi, MI,).
1- [2-Hydroxy-3-(N,N- di-methyl-N-hydroxyethyl)ammoniopropyl]-4-[β-[2-(di-n- butylamino)6-napthyl] vinyl]pyridinium dibromide (di-4-ANEPPDHQ) (Cat# D36802) was from
ThermoFisher (Waltham, MA). Titanium dioxide P225 (81% anatase, 19% rutile) zinc oxide were
from Meliorum Technologies Inc. (Rochester, NY) and Evonik (Parsippany, NJ), respectively.
Methyl-ß-cyclodextrin was (CAT# C4555) was from Sigma- Aldrich (St. Louis, MO). All
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materials used were spectroscopic grade. Glass bottom cell culture dishes (CAT# 627871) were
from Greiner Bio-One North America Inc. (Monroe, NC).

Preparation of RBC for FLIM

RBC stock vial (25% cells/solution) was aliquoted in 1-ml samples and centrifuged for 5 minutes
at 10,000 RCF. The supernatant was removed, and the cell pellet was suspended in 1 ml of tris
buffered saline (TBS) (pH 7.4, 50 mM tris, 150 mM NaCl) by pipetting and gently inverting the
tube several times. This RBC suspension was then diluted 1:20 in TBS. ENM or silica were
suspended in TBS at 1mg/ml and sonicated for 2 minutes at 40% intensity in a Qsonica Q500
(Newtown, CT). ENM/silica were added to the RBC-containing tubes at the final concentrations
ranging from 25- 200 µg/ml. The RBC/particle mixtures were then incubated at 37˚C for 4 hours
on a rotating tube rack. Di-4-ANEPPDHQ was dissolved in spectral grade DMSO (final volume
of DMSO less than 1% of the total solution volume) and added to each tube at 400 nM final
concentration, and the tubes were incubated at room temperature for 15 minutes on a rotating tube
rack. For RBC treated with methyl-ß-cyclodextrin (solubilized in Milli-Q purified water), RBC
were prepared as previously described and mixed with methyl-ß-cyclodextrin at 1.2 mM for 30
minutes at 37˚C on a rotating tube rack. Di-4-ANEPPDHQ was added as previously described
prior to imaging. Zinc sulfate treatment of RBC was such that the amount of zinc ions would be
equivalent to the amount of ZnO dissolved after 24 hours at pH 7.4 [29]. Di-4-ANEPPDHQ was
added as described above.
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Imaging and Analysis of RBC FLIM

FLIM was used to investigate ENM/silica-induced changes to RBC membrane properties. FLIM
directly measures the fluorescence lifetime of a fluorophore on a pixel-by-pixel basis. The
fluorescence lifetime of a given fluorophore is thecombination of radiative and non-radiative
relaxation processes that result in the return of the fluorophore from the singlet excited state to the
singlet ground state. Increased dynamic interactions between excited-state di-4-ANEPPDHQ and
membrane phospholipids will increase the non-radiative decay processes and shorten the
fluorescence lifetime. The average fluorescence lifetime is defined in eq. #1.

𝝉𝑨𝒗 𝑰𝒏𝒕 =

∑𝒏C𝟏
𝒌E𝟎 𝑰 [𝒌] 𝝉 [𝒌]
𝑰𝑺𝒖𝒎

1)

In this equation, 𝝉 Av Int corresponds to the average intensity- weighted fluorescence lifetime. The
values I and 𝝉 represent the fluorescence intensity and lifetime of each exponential component of
the fluorescence decay. The sum of the fluorescence intensities is defined by ISum.

After incubation of RBC, 50 µl of RBC sample was placed into a cell culture dish with a glass
bottom. Images were taken on a MicroTime 200 time-resolved inverted confocal microscope,
PicoQuant GmbH (Berlin, Germany). All measurements were at room temperature (~20˚C) using
a 60X 1.2 NA water immersion objective and excitation from a vertically polarized 485-nm pulsed
laser diode (20MHz). To capture the desired emission of di-4-ANEPPDHQ, a 582/75 bandpass
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filter was used. Each sample was imaged so that 8-10 random fields were scanned. Prior to
analyzing each field, any saturated pixels or pixels significantly brighter than the rest of the image
were cropped out of the field. These pixels were removed because the fluorescence intensity was
above the set threshold. If a pixel contained greater than 1% of the total intensity of the entire
image, it was excluded. The intensity-weighted fluorescence lifetime for each field was fitted using
PicoQuant SymPhoTime 64 Software. Dark background pixels with no fluorescence did not count
towards the intensity-weighted fluorescence lifetime. The overall calculated fluorescence lifetimes
of all cells in each field (8-10 fields per sample) of a given sample were averaged to generate the
overall average fluorescence lifetime of that experimental replicate. This was repeated three to
four times, in order to produce independent replicates. An exponential reconvolution with three
model parameters and a calculated IRF was used to fit the data. An example of a fitted decay is
shown in Supplemental Figure 1.

Time-resolved Fluorescence Anisotropy
Fluorescence anisotropy measures the amount of fluorescence emission depolarization of the
membrane incorporated probe, where the amount of depolarization can be attributed to changes in
lipid order. The anisotropy was determined by eq. #2. Anisotropy is defined by the value r(t), while
total emission intensity is defined by I(t) and vertical and horizontal emission decays are Ivv(t) and
Ivh(t), respectively. The anisotropy data was analyzed by the wobble-in-a-cone model, which
represents the rotational range of motion of the probe in the membrane within an angle, 𝜽, as
calculated in eq. #3 [43].
𝒓(𝒕) =

𝑰𝑽𝑽 (𝒕) − 𝑰𝑽𝑯 (𝒕)
𝑰𝑽𝑽 (𝒕) + 𝟐𝑰𝑽𝑯 (𝒕)

2)
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𝑺𝟐 =

𝟐
𝒓0
𝟏
= 2 𝐜𝐨𝐬(𝜽) (𝟏 + 𝐜𝐨𝐬(𝜽))8
𝒓𝒐
𝟐

3)

The term S is defined as the order parameter and is the ratio of the residual anisotropy, r¥,, to the
initial anisotropy, r0. This relationship between r¥, and r0 represents the rotational freedom of the
probe as defined in the wobble-in-a-cone angle, 𝜃.

Fluorescence anisotropy measurements were taken on a custom-built time-resolved fluorimeter
(Quantum Northwest, Liberty Lake, WA). A 470-nm pulsed diode laser (LDH-P-C- 470;
PicoQuant GmbH, Berlin) was used to excite the probe. Fluorescence emissions passed through a
500-nm longpass filter (Chroma, Bellows Falls, VT) and was detected by an Edinburgh
Instruments (Livingston, UK) Photomultiplier Tube (H10720–01) using time-correlated singlephoton counting. Measurements were taken at 20˚C ± 0.01 ˚C. RBC were prepared as previously
described for FLIM. The RBC sample was gently stirred before anisotropy measurements were
taken. An example of a fitted fluorescence decay is shown in Supplemental Figure 2.

Statistical Analysis

When comparing two means, two-tailed, unpaired t-tests were used. When comparing multiple
different means to the mean of a control samples, one-way ANOVA with Dunnett post- test, were
performed using GraphPad Software (San Diego, CA) Prism 6.0. P-values<0.05 were determined
to be statistically significant.
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Results
Human RBC were selected for use in these experiments in order to relate particle-induced
membrane changes to reported hemolysis data, and to simulate a more complex biological
membrane that may more closely represent that of various cells. The particles selected in this study
were titanium dioxide (TiO2), zinc oxide (ZnO), and crystalline silica. Silica was chosen as a
positive control because it is widely reported to trigger inflammatory responses in vivo and in
vitro, as well as cause hemolysis [14, 19, 27]. The two ENM chosen, TiO2 and ZnO, were selected
because of their similar average size to each other, which is 24 and 20 nm, respectively and
availability of reports of membrane damage or hemolysis [17, 19, 27, 23, 29]. Also, both ENM are
easily dispersed in TBS, which was used to suspend the RBC.

In this work, di-4-ANEPPDHQ was selected as the fluorescence probe because it partitions into
both the ordered and disordered phases of lipid membranes and exhibits phase-dependent
fluorescence decay. This probe has been previously characterized by our laboratory and others in
various model membrane systems or live cells and has been reported to be sensitive to changes in
lipid membrane order resulting in shifts in emissions spectra and changes to fluorescence lifetime
and anisotropy [34-41].

FLIM measurements of di-4-ANEPPDHQ fluorescence in RBCs treated with methyl-ßcyclodextrin to extract membrane incorporated cholesterol were performed prior to treatment with
ENM or silica to understand how this probe would respond to a more disordered RBC membrane
versus a more ordered one [41, 42]. The data are displayed in Figure 1. Treatment with methyl-ßcyclodextrin prior to FLIM caused a significant decrease to the fluorescence lifetime of di-455

ANEPPDHQ. This is congruent with the interpretation that a more disordered/fluid membrane will
result in more dynamic non-radiative decay events for the probe and thus reduce its fluorescence
lifetime. All numerical values for FLIM data are shown in Supplemental Table 1.
*

Figure 1: FLIM Analysis of RBC treated with methylß-cyclodextrin. RBC were treated with
1.2 mM methyl-ß-cyclodextrin for 30 minutes prior to
imaging. Error bars indicate mean +/- SEM. n=4

This decrease to membrane order from methyl-ß-cyclodextrin treatment was also analyzed with
time-resolved fluorescence anisotropy measurements of di-4-ANEPPDHQ in RBC membranes.
The cone-angle data of RBC treated with methyl-ß-cyclodextrin is shown in Figure 2. After
cholesterol extraction, the cone angle of the probe significantly increased, which indicates that the
membrane has become more disordered and thus di-4-ANEPPDHQ has more rotational freedom.
Numerical values for the anisotropy data are shown in Supplemental Table 2.
cone angle (degrees)
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Figure 2: Time-resolved Anisotropy of RBC Treated with methyl-ßcyclodextrin. RBC were treated with 1.2 mM methyl-ß-cyclodextrin
for 30 minutes prior to taking anisotropy measurements. Error bars
indicate mean +/- SEM. n=3
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In order to determine the effects of particles on membranes, RBC were treated with ENM or silica
for 4 hours at doses ranging from 25-200 µg/ml. Figure 3 displays an RBC dose response with
TiO2.

Figure 3: FLIM Dose Response of RBC Treated by
TiO2. RBC were treated with doses of TiO2 ranging
from 25-100 µg/ml for 4 hours before FLIM. Error bars
indicate mean +/- SEM. n=3-4

The RBC treated with TiO2 had a statistically significant change in the fluorescence lifetime of di4-ANEPPDHQ between the 50 and 100 µg/ml doses. Here, the fluorescence lifetime in the treated
RBC increased, indicating that there may be increased lipid order. Changes to the structure and
fluorescence lifetime of the RBC can be seen in Figure 4, which displays FLIM images of control
cells compared to TiO2-treated cells. In the FLIM images, the control cells (left image) have a
more uniform appearance and structure, while the TiO2-treated cells (right image) appear to have
a clumped appearance. The changes in lifetime and morphology are consistent with an interaction
between the particles and RBC that causes disruption of the membrane and thus results in a
different physical appearance of the cells and altered membrane properties.
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Figure 4: FLIM Images of RBC Treated with TiO2. RBC were treated
with TiO2 for 4 hours. Shown are control RBC on the left and 100 µg/ml
TiO2-treated cells on the right. Brighter parts of the image represent
increased fluorescence intensity. A scale for fluorescence lifetime is
shown in the middle.

The RBC were next treated with ZnO. At the 100 µg/ml dose of ZnO, the fluorescence lifetime
significantly decreased, which is seen in Figure 5. This decrease is similar to that observed with
cholesterol extraction from the RBC, indicating a more disordered membrane. Because ZnO
readily dissolves, especially under acidic conditions, treatment of RBC with soluble zinc sulfate
was used as a control to determine if the changes to the RBC induced by ZnO were from zinc ions
in solution or the ZnO particles themselves [29]. In Figure 6, RBC were treated with 20 µg/ml
ZnSO4 for 4 hours, in order to simulate the fractional dissolution rate of ZnO particles over 4 hours
(~10%) in a neutral pH buffered solution [29]. Treatment with ZnSO4 did not affect the
fluorescence lifetime significantly, demonstrating that the changes to the RBC observed were a
result of ZnO nanoparticle interactions with the RBC. The FLIM images of ZnO-treated appeared
to have more blue pixels, indicating a shorter fluorescence lifetime. An example of this is shown
in Figure 7. The control cells are in the leftmost image, while the cells treated with 100 µg/ml of
ZnO are in the rightmost image.
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Lastly, the RBC were treated with crystalline silica. A similar result to that produced by TiO2 was
observed and is displayed in Figure 8. The two highest doses of silica (100 and 200 µg/ml) caused
a significant increase to the fluorescence lifetime. Again, this indicates that the di-4- ANEPPDHQ
is in a more ordered environment in the RBC membrane.

Figure 5: FLIM Dose Response of
RBC Treated with ZnO. RBC
were treated with does ranging
from 25-100 µg/ml of ZnO for 4
hours before FLIM measurements.
n=3

Figure 6: RBC Treated with ZnSO4
for FLIM. RBC were treated with
20 µg/ml of zinc sulfate for 4 hours
prior to FLIM. error bars indicate
mean +/- SEM. n=3

FLIM images of silica-treated RBC are shown in Figure 9. In response to 100 µg/ml silica
treatment, the cells became less uniform in appearance and exhibited increased fluorescence
lifetimes. The fluorescence intensity of the images, measured separately, was also slightly dimmer,
possibly because of silica-induced hemolysis of RBC damaging membranes, thus resulting in less
di-4-ANEPPDHQ in the membrane and less fluorescence. Since the changes to the fluorescence
lifetime were observed among particles of different sizes (ENM versus silica), estimated availablesurface-area calculations of spherical particles of equivalent volume were made to examine the
effect of available surface area on changes to fluorescence lifetime in RBC; these are presented in
Table 1. Due to their smaller size (~20 nm compared to ~2 µm), the ENM have a larger available
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surface area than crystalline silica, which may explain the greater effect of ENM on the RBC
membranes and fluorescence lifetime relative to silica when compared on the basis of a
weight/volume dosage.

Figure 7: FLIM Images of RBC Treated with ZnO. RBC were
treated with ZnO for 4 hours prior to imaging. Control cells
are show in the image on the left, while the image on the right
shows a 100 µg/ml dose of ZnO. Brighter parts of the image
represent increased fluorescence intensity. A scale for
fluorescence lifetime is shown in the middle.

Figure 8: FLIM Dose Response of RBC
Treated with Crystalline Silica. RBC
were treated with doses of silica ranging
from 25-200 µg/ml for 4 hours before
FLIM. Error bars indicate mean +/SEM. n=3-4
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Figure 9: FLIM Images of RBC Treated with Silica. RBC
were treated with crystalline silica for 4 hours prior to
imaging. Control cells are seen in the image on the left,
while the image on the right has 100 µg/ml silica treated
cells. Brighter parts of the image represent increased
fluorescence intensity. A scale for fluorescence lifetime is
shown in the middle.

Table 1. Available Surface Area Calculations of ENM or Silica

Material

Density
(g/cm3)

Size (nm)

SA (m2/g)

TiO2

3.9

24

32.05

ZnO

5.06

20

29.64

SiO2

2.3

1750

0.75

Discussion
FLIM provided fluorescence lifetime measurements for ENM- versus silica-induced membrane
changes in RBC that could be associated with morphological changes observed in cells. Similar to
the results of Owen et al., we observed decreases in fluorescence lifetime after treatment with
methyl-ß-cyclodextrin [41]. Thus, FLIM combined with time- resolved fluorescence anisotropy
measurements demonstrates how the di-4-ANEPPDHQ fluorescence lifetime responds to changes
in membrane order: a shorter fluorescence lifetime is associated with a larger wobble-in-a-cone
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angle, which is diagnostic of a more disordered membrane; conversely, a longer fluorescence
lifetime is associated with a smaller wobble-in-a-cone angle, which is diagnostic of a more ordered
membrane.

Here, it was seen that TiO2 and silica were two materials that caused an increase in the di-4ANEPPDHQ fluorescence lifetime. Based on the fluorescence lifetime changes in the
corresponding images, it appears that these materials have an interaction with RBC that alters
membrane properties and increases lipid order. On the other hand, ZnO interaction with RBC
causes a decrease in the fluorescence lifetime, which indicates a decrease in lipid order.

In investigations of other model membrane systems, it has been proposed that ENM can interact
with membranes and cause restriction of lipid motion, which may explain why TiO2 and silica
cause increased fluorescence lifetimes [37, 44]. For example, other studies have used liposome
model systems to examine the interaction between ENM and lipid membranes, which reported that
ENM adsorb to liposomes and that this process leads to a membrane that can leak calcein [44].
Another time-resolved fluorescence anisotropy study, previously published in our laboratory,
demonstrated that treating liposomes with ENM can cause an increase in membrane order and that
the composition of the liposomes is important in this change to membrane properties [37]. The
effect produced by ZnO on the fluorescence lifetime is a decrease, and may be caused by
differences in surface properties compared to TiO2 and silica, of which the effects are not currently
understood. Because there are differences among these materials in terms of how they disrupt
membranes, there may be more than one mechanism of membrane disruption that can eventually
lead to hemolysis and permeability. One proposed mechanism of interaction between silica and
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membranes is between nearly-free silanols on the surface of the silica and the phosphate group of
phosphatidylcholine [45]. This demonstrates the importance of understanding the surface
properties of different materials and how they interact with phospholipids.

Conclusion

It is important to consider that RBC membranes are much more complex than most model systems,
which generally are comprised of one or two types of lipids and depending on differences in head
groups and acyl chains, may be susceptible to membrane disruption in different ways. Future work
will need to be done to understand and translate changes seen in model membranes to those of
more complex cellular systems. Understanding these changes at the molecular level, using
fluorescence probes for FLIM and time-resolved fluorescence anisotropy, may help toward
understanding the propensity of ENM and silica to cause hemolysis, altered membrane
permeability, or inflammation.
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Supplementary Data

Supplemental Figure 1: Fitted Lifetime Decay Curve of Control RBC with PicoQuant SymPhoTime 64 Software.
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Supplemental Figure 2: Time-resolved Anisotropy Decay Curves. The top
graph shows vertically (90˚) polarized excitation with vertically polarized
emission. The bottom graph shows vertically polarized excitation with
horizontally (0˚) emission.
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Supplemental Figure 3: High Resolution FLIM Images of
RBC Treated with TiO2. RBC were treated with TiO2 for 4
hours. Shown here are control RBC on the left and 100 µg/ml
TiO2 treated cells on the right. Fluorescence patten matching
was used to generate these images. This results in a higher
quality image with less noise. A color scale for fluorescence
lifetime changes can be seen in the middle. Brighter pixels
represent increased fluorescence intensity.

Supplemental Figure 4: High Resolution FLIM Images of
RBC Treated with ZnO. RBC were treated with ZnO for 4
hours prior to imaging. Control cells are show in the image on
the left, while the image on the right shows a 100 µg/ml dose
of ZnO. Fluorescence patten matching was used to generate
these images. This results in a higher quality image with less
noise. A color scale for fluorescence lifetime changes can be
seen in the middle. Brighter pixels represent increased
fluorescence intensity.
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Supplemental Table 1. Intensity Weighted Fluorescence Lifetime Values
Sample
Control
MßCD
25 µg/ml TiO2
50 µg/ml TiO2
100 µg/ml TiO2
20µg/ml ZnSO4
25 µg/ml ZnO
50 µg/ml ZnO
100 µg/ml ZnO
25 µg/ml SiO2
50 µg/ml SiO2
100 µg/ml SiO2
200 µg/ml SiO2

Intensity-weighted
Fluorescence
Lifetime
2.893 ± 0.16
2.40 ± 0.125
3.12 ± 0.134
3.30 ± 0.135
3.395 ± 0.104
2.897 ± 0.039
2.8875 ± 0.027
2.683 ± 0.123
2.503 ± 0.082
2.994 ± 0.016
2.908 ± 0.133
3.10 ± 0.2
3.19 ± 0.066

Supplemental Table 2. Anisotropy of RBC Treated with Methyl-ß-cyclodextrin
Sample

R0

R∞

Cone
Angle

Control

0.225
±
0.047
0.22
±
0.03

0.194
±
0.046
0.138
±
0.036

17.88
±
2.487
31.21
±
6.457

MßCD
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Abstract

Human inhalation exposure to silica dust has been linked to silicosis, lung cancer, and chronic
inflammatory disease. Deposition of silica particles in the alveolar space of the lung results in
uptake of these particles by alveolar macrophages (AM). A key step in the inflammatory response
and development of silicosis is silica-induced phagolysosomal membrane permeability (LMP) in
AM. This process causes leakage of lysosomal contents into the cytosol, formation of the NLRP3
inflammasome, and subsequent release of IL-1ß and IL-18. Since LMP has such a deterministic
effect on the inflammatory response, it is important to understand the mechanisms by which silica
can disrupt membranes and cause permeability. This study took advantage of variability among
different silicates to determine mechanistic correlations leading to inflammation. Five different
silicate materials were analyzed for nearly free silanol (NFS) functional groups on their surfaces,
which can be formed as a result of fracturing or heating. The presence of NFS has been associated
with increased toxicity and inflammation. Silica-induced membrane permeability was measured
using a human red blood cell (RBC) hemolysis assay. Four of the five materials tested contained
NFS on their surfaces, which produced discrete dose-dependent hemolysis curves. The silicateinduced hemolysis of NFS containing materials corresponded to cytotoxicity and IL-1ß release in
bone marrow derived macrophages. In order to determine if each silicate could interact with and
cause changes to the lipid order of membranes, time-resolved fluorescence anisotropy
measurements of 100 or 500-nm liposomes incorporated with the fluorescence probe, Di-4ANEPPDHQ, were conducted. The liposomes were composed of either DOPC or DOPS. In a
NFS-dependent manner, the various silicates produced significant changes to the lipid order of
DOPC liposomes, but not in DOPS liposomes. Taken together these results indicate that the
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presence of NFS formed by fracturing or heating caused hemolysis and increased bioactivity in
macrophages, as well as membrane disruption in liposomes. These functional surface groups may
target neutral headgroup phospholipids such as phosphatidylcholine, as the initial step inducing
LMP and explain the different levels of bioactivity among silicates.

Introduction

Human exposure to silica has been occurring for hundreds of years. Occupational exposure to
silica such as in sandblasting, construction or quarrying can lead to the production of a respirable
fraction of the material[1–4]. Inhalation of silica has been associated with silicosis, which is
marked by lung scarring and pulmonary fibrosis. From 1999-2013 silicosis was listed as the cause
for more than 40000 deaths per year [5]. It is estimated that approximately 2 million workers are
exposed to silica in the United States every year [6]. Furthermore, silica-induced diseases are a
worldwide concern especially in developing nations [1]. Inhalation of silica has also been
associated with lung cancer and autoimmune disorders [7–9].

Respirable silica can become aerosolized and deposit into the lungs. Silica that deposits into the
alveolar space can be encountered and phagocytosed by alveolar macrophages [10–12]. Eventually
the phagosome that contains the silica will fuse with the lysosome, forming the phagolysosome.
These acidic vesicles, degrade most biomolecules, however, silica is not degraded and can trigger
a process known as phagolysosomal membrane permeability (LMP) in which the proteases
normally contained within the phagolysosome are released into the cytosol [13–16]. Consequently,
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these enzymes can cause mitochondrial damage along with the formation of the NLRP3
inflammasome, which functions to activate caspase-1, which cleaves pro-IL-1ß and pro-IL-18 to
their active forms prior to secretion [17–21]. It is predicted that the ability of silica to cause LMP
is the key step in this pathway that determines the inflammatory response and that the surface
properties of the silica contribute to its ability to cause membrane permeability.

In order to better understand the differences in bioactivity among silicate materials, five different
silicates were analyzed for nearly free silanols on the surface of the materials. Nearly free silanols
(NFS) are Si-OH groups on the silica surface that are 4-6 Å separated from each other and have
weak interactions among other silanols on the surface of the material [22]. These NFS represent a
possible functional group that can interact with and permeabilize membranes. The hypothesis of
this study was that the NFS content will determine impacts on phospholipid membranes and
bioactivity in RBC (hemolysis) and bone marrow derived macrophages (BMdM, toxicity and
activation). Hemolysis assays used human RBC while cytotoxicity and NRLP3 inflammasome
activation (IL-1 ß release) used murine BMdM. Silicate-induced changes to lipid membranes were
determined by calculating the wobble-in-a-cone angle from time-resolved anisotropy
measurements of the fluorescence probe, Di-4-ANEPPDHQ, in liposomes used to model the
phagolysosome of macrophages.
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Materials and Methods

Lipids and other reagents
All phospholipids were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL) already in
chloroform. The lipids used were as follows: 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)
(Cat# 850375), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (DOPS) (Cat# 840035).
Di-4-ANEPPDHQ (Cat# D36802), which served as the fluorescence probe was from
ThermoFisher (Waltham, MA). Crystalline silica (min-u-sil-5) was from Pennsylvania Glass Sand
Corp. (Pittsburgh, PA). Other types of synthetic or fractured quartz were supplied by Dr. Francesco
Turci and prepared as previously described [22,23] . Complete growth media for cell culture
consisted of HEPES-buffered RPMI 1640 supplemented with L-glutamine (10-041-CV Corning,
NY). Heat inactivated fetal bovine serum (35-016-CV, Corning) was added to a final concentration
of 10%. Additionally, Beta mercaptoethanol (0.05 mM), Penicillin-Streptomycin (1%, 100U/ml),
and 1 mM sodium pyruvate (30-002-CI and 25-000-CI, Corning) were also added to the growth
media, which was filter sterilized before use. The lactate dehydrogenase (LDH) assay kit was
bought from Promega (G7890, Madison, WI). For detection of IL-1ß, the mouse IL-1ß ELISA kit
(DY-405) was used from R&D Systems (Minneapolis, MN).
Bone Marrow Derived Macrophages (BMdM)
Bone marrow was flushed with complete growth media from the femur and tibia of C57Bl/6 mice
from Jackson Laboratories (Bar Harbor, ME) and collected in T75 flasks filled with 20 ml of
complete growth media. These cells were incubated overnight for stromal cell elimination. After
removing the stromal cells which stuck to the T75 flasks, all remaining cells were seeded with 40
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µl of macrophage colony stimulating factor (M-CSF) from a 10 µg/ml stock solution R&D
Systems (416-ML, Minneapolis, MN). An additional 20 µl of M-CSF was added on day 4 with a
50% media change and additional 20 µl of M-CSF added on day 7. Cells were used 10 days
following stromal elimination.
Preparation of Silicates Prior to Use
Stock solutions of each silicate were prepared at a 1-4 mg/ml concentration in either TBS (50 mM
tris pH 7.4, 150 mM NaCl) or complete growth media. Each material was sonicated in a Qsonica
(Newtown, CT) Q500 sonicator for 2 minutes at 40% amplitude in order to create a particle
suspension. Doses of each material were administered to liposomes for 2 hours or to BMdM for
24 hours.
Preparation of Liposomes
Each desired lipid dissolved in chloroform was dried under a stream of nitrogen gas for
approximately 1 hour. The dry lipid film was then hydrated with TBS (50 mM tris pH 7.4, 150
mM NaCl) and sonicated in a bath sonicator for 10 min. The hydrated lipid solution was then
passed through an Avanti Mini-Extruder with appropriately sized filter for 15 extrusions. During
preparation, the lipids were kept 10°C above their respective transition temperature with a heated
water bath or heating block. The size of the liposomes was checked using dynamic light scattering
on a Malvern Zetasizer (Malvern, UK). When incubated with silicate materials, liposomes were
placed at 37°C with tumbling for 2 hours. Di-4-ANEPPDHQ was prepared in spectral grade
DMSO and diluted to a 250 µM stock in TBS. The final working concentration of Di-4-
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ANEPPDHQ was at 400 nm (final DMSO concentration <1%) and was added 15 minutes prior to
data collection at room temperature.
Time-Resolved Fluorescence Anisotropy
Fluorescence measurements were taken on a custom-built fluorimeter with parts from Quantum
Northwest (Liberty Lake, WA) as previously described [24]. Di-4-ANEPPDHQ was excited with
a 470-nm pulsed diode laser (LDH-P-C-470; PicoQuant, Berlin GmbH). Fluorescence emissions
passed through a Chroma 500-nm longpass filter (Bellows Falls, VT) and detected using an
Edinburgh Instruments (Livingston, UK) photomultiplier tube (H10720–01). All measurements
were taken from a temperature controlled chamber at 20 ± 0.02°C. Anisotropy decay
measurements were fit and analyzed using FluoFit v4.6.6 (PicoQuant, Berlin GmbH).

Hemolysis Assay

Human red blood cells (RBC) were isolated and collected as previously described [22]. Prior to
silicate treatment, RBC were suspended in Dulbecco’s phosphate buffered saline (PBS). RBC were
incubated with silicates for 30 minutes at room temperature prior to centrifugation and measuring
hemoglobin absorbance in the supernatant at 540 on an Infinite 200 UV/vis spectrophotometer
(Tecan, Switzerland). Triton X-100 served as a positive control for complete RBC lysis. Results
were calculated as a percentage of complete lysis.
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Statistical Analysis

All statistical comparisons were between more than two means, so a one-way ANOVA was used.
In order to compare each experimental mean to that of the control, a Dunnett post-test was used.
All tests were two-tailed with significance determined by p <0.05.

Results

Five different silicate materials were tested in order to determine the implications of variable
amounts of NFS on inducing membrane permeability and toxicity. Crystalline silica, or min-u-sil5 (SSA 4.3 m2/g) was used as the reference material because of the extensive testing that has been
done to determine its role in causing LMP and inflammation. Synthetically as-grown quartz (gQ,
SSA 5.8 m2/g) was used for the purpose of comparing how fracturing quartz impacts its bioactivity.
The gQ material was fractured in either a planetary ball mill or a mixer mill to produce gQ-f (SSA
10.7 m2/g) or gQ-f (SSA 3.2 m2/g), respectively. Additionally, vitreous silica (VS, SSA 23-27
m2/g) was used to examine the effects heating during sample production on its bioactivity
compared to the other materials selected. All materials except for gQ and gQ-f (10.7) (analysis
still in determination) contained NFS on the surface of the material as previously determined [22].

Hemolysis of RBC has been used in a number of studies to demonstrate the membranolytic
properties of silica as well as other materials [22,25,26]. In this work, human RBC were treated at
Dr. Turci’s laboratory with various doses of each of the five silicates mentioned above for 30
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minutes. These data are shown in Figure 1. All materials except for gQ and gQ-f (10.7) produced
statistically significant hemolysis. Both gQ and gQ-f (10.7) were determined to not contain
measurable NFS on their surfaces, which potentially explains their low hemolytic activity.
Vitreous silica produced the largest amount of hemolysis followed by min-u-sil-5 and gQ-f.

The four silicates that produced the most hemolysis (gQ excluded) mentioned above were
incubated with BMdM for the purpose of investigating the relative bioactivity of each material
using murine macrophage-like cells. These cells were used as models for what may happen in vivo
when silica is inhaled and encountered by alveolar macrophages. Two different assays were done
with BMdM. The LDH assay measures lytic cell death and toxicity, while IL-1ß release is a proxy
for the inflammatory potential of each material to cause NLRP3 inflammasome activation. Both
of these assays represent cellular events that can be downstream of LMP. Figure 2 displays LDH
release of silicate treated BMdM for 24 hours. The results of the LDH assay were similar in their
pattern to that of the hemolysis assay in Figure 1. Min-u-sil-5 and vitreous silica produced the
highest level of LDH release, as seen in Figure 2A and Figure 2D. Figure 2E displays all materials
tested compared to one another. Again, vitreous silica was the most potent material followed by
min-u-sil-5 and gQ-f (3.2), meaning that all of the silicates with NFS cause both RBC hemolysis
as well as cytotoxicity in macrophages.

80

Min-U-Sil 5

A

80

80
70

60

***

50

***

% Hemolysis

% Hemolysis

70

***

40

***

30
20

ns

**

10
0

60
50
40
30
20
10

0

6.25 12.5 25

50

100 200

0

2

cm /ml

ns

ns

6.25 12.5 25

50

ns

0

gQ-f (SSA 3.2)

ns

100 200

cm2/ml

70

60
50

***

% Hemolysis

% Hemolysis

ns

D

80

70

***

***

40

***

30
20

ns

**

10

60
50
40
30
20
10

0

6.25 12.5 25

E

50

100 200

2

cm /ml

0

0

6.25 12.5 25

50

100 200

cm2/ml

vS
***

80
70

% Hemolysis

ns

gQ-f (SSA 10.7)

C

80

0

gQ

B

***

60

**

50

*

40
ns

30
ns

20
10
0

0

6.25 12.5 25

50

100 200

cm2/ml
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Figure 2: LDH Release from Bone Marrow Derived Macrophages Treated with Silicates for 24
hours. (A-D) display the LDH release caused by each silicate displayed as surface are. (E) shows
weight/volume doses of all silicates compared to one another. * denotes p<0.05 n=3.

The inflammatory potential of each silicate was next analyzed by their ability to cause IL-1ß
release in BMdM exposed for 24 hours. These results are displayed in Figure 3.
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Figure 3: IL-1ß Release from Bone Marrow Derived Macrophages Treated with
Silicates for 24 hours. (A-D) display the LDH release caused by each silicate
displayed as surface are. (E) shows weight/volume doses of all silicates compared
to one another. * denotes p<0.05 n=3.

Min-u-sil-5, gQ-f (3.2), and vitreous silica produced statistically significant increases to IL-1ß
release as seen in Figure 3A, 3B, and 3D. gQ-f (10.7) did not produce a significant amount of IL1ß release, which was to be expected as this material did not cause hemolysis or LDH release.
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When examining Figure 3E, the trend in terms of relative bioactivity is maintained as vitreous
silica and min-u-sil-5 are the two most bioactive materials with gQ-f (3.2) also somewhat
bioactive. Since vitreous silica, min-u-sil-5, and gQ-f (3.2) have all produced significant changes
in the first three assays performed, it is predicted that these materials cause the most membrane
disruption and LMP. The hemolysis assay demonstrated the membranolytic potential of each
silicate, while LDH and IL-1ß release demonstrate the inflammatory potential of each material
with the observation of two events downstream of LMP.

While LMP has been observed with a variety of silicates and other materials, the process by which
these materials cause membrane permeability is not fully clear. In order to understand the
mechanisms of silica-induced membrane permeability and bioactivity, controlled liposome model
systems were used to measure changes to membrane order caused by silicate treatment. The
liposomes were composed of one of two phospholipids, which were DOPC and DOPS. These
phospholipids are biologically relevant and some of the most prevalent in the lysosomes of
mammalian cells and are displayed in Table 1 [27].
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Table 1. Phospholipids Used for Liposome Model Systems.
Overall
Lipid

Structure
Charge

DOPC

Neutral

DOPS

-1

Changes to membrane order were measured by time-resolved fluorescence anisotropy of a
lipophilic fluorescence probe, Di-4-ANEPPDHQ. Time-resolved anisotropy measures the rate of
fluorescence depolarization of a fluorophore. In lipid membranes this depolarization can be a
measure of lipid order. Di-4-ANEPPDHQ is solvatochromic and partitions into both the ordered
and disordered phases. It has also displayed sensitivity to lipid order in cells and model systems
[28–31]. The anisotropy parameter is determined by equation #1

(1
𝑟 (𝑡 ) =

𝐼)) (𝑡) − 𝐼)+ (𝑡)
𝐼)) (𝑡) + 2𝐼)+ (𝑡)
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The anisotropy is defined by the value, r. The total fluorescence intensity is defined by the term
I(t). The vertical and horizontal emission decays are IVV and IVH, respectively. The range of motion
of Di-4-ANEPPDHQ was then calculated by a wobble-in-a-cone angle, as shown in equation #2
[32].

(2
𝑆/ =

/
𝑟0
1
= 2 cos(𝜃) (1 + cos(𝜃))8
𝑟1
2

The order parameter, S, represents the order of a lipid membrane and is calculated by the ratio of
r¥:r0. The initial anisotropy in a lipid membrane is r0, while the residual anisotropy that the
fluorescence probe decays to is the term, r¥. This relationship between r0 and r¥ can be used to
establish a range of motion of the fluorescence probe, or a wobble-in-a-cone angle, θ.

Each silicate material was tested with DOPC liposomes in order to observe changes to lipid order
from an interaction between the silicates and the phospholipids in the membrane. Figure 4 displays
anisotropy data from 100-nm liposomes treated with silicates for 2 hours. Doses ranged from 200400 µg/ml. This dose range was determined to not cause light scatter in the anisotropy experiments.
Higher doses of silicates needed to normalize surface area between materials caused light scatter,
which biases the fluorescence decay data. Every material except for gQ, Figure 4B, produced a
significant decrease to the cone angle of Di-4-ANEPPDHQ, indicating that there is an increase in
lipid order caused by these materials interacting with DOPS liposome membranes. In particular,
gQ-f (10.7) also produced a significant change to the cone angle, but this material did not produce
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hemolysis or LDH/IL-1ß release in BMdM. The rest of the silicates that have surface NFS caused
a change to the lipid order, which was expected based on their hemolytic ability.
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Figure 4: Time-Resolved Anisotropy of 100-nm DOPC Liposomes Treated
with Silicates for 2 hours. Cone-angle data is displayed for DOPC liposomes
treated with various doses of silicates for 2 hours at 37°C. * indicates
p<0.05, n=3
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In order to further examine why gQ-f (10.7) is active in the liposome model, but not in RBC or
BMdM, the size of the liposomes were increased to 500 nm. Larger diameter liposomes have
different curvature, which can change the orientation of phospholipids on near NFS on the surface
of the silicates. Figure 5 displays a comparison between gQ-f (3.2) and gQ-f (10.7). In Figure 5A,
gQ-f (3.2) produced a decrease to the cone angle which was similar to that of the 100-nm DOPC
liposomes, while gQ-f (10.7) did not produce a significant change to the cone angle of the 500-nm
liposomes. Figure 5B displays a result that was more comparable to the outcome of the hemolysis
assay, while gQ-f (10.7) was not active.

A

B

Figure 5: Time-Resolved Anisotropy of 500-nm DOPC Liposomes
Treated with Silicates for 2 hours. Cone-angle data is displayed for
DOPC liposomes treated with various doses of silicates for 2 hours at
37°C. * indicates p<0.05, n=3

All materials were next tested on acidic DOPS liposomes. At pH 7.4, DOPS carries a net -1 charge
and was used to understand the role that phospholipid headgroup charge played in interactions
with silicates. Figure 6 displays these data. No material induced a significant change to the cone
angle. This is interpreted as there being minimal or no interactions between the liposomes and
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silicates. Because all of the silicates produced some change to the DOPC liposomes, there is likely
charge repulsion occurring between the negatively charged surface of the DOPS liposomes and
that of the silicates.
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Figure 6: Time-Resolved Anisotropy of 100-nm DOPS Liposomes
Treated with Silicates for 2 hours. Cone-angle data is displayed for DOPS
liposomes treated with various doses of silicates for 2 hours at 37°C. *
indicates p<0.05, n=3
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Discussion

Exposure to crystalline silica, primarily in occupational settings, remains a global health problem
despite decades of research. Although cases of silicosis have been slowly declining in recent years
there is a concern that trend may reverse in part due to increased exposures to workers in the granite
countertop industry. The lack of effective therapeutic approaches is limited by the lack of
comprehensive mechanistic understanding of silica-related diseases. The work in the present study
was focused on the proposed initiating events leading to LMP in macrophages following
phagocytosis of respirable sized silica. To test the hypothesis that NFS on the surface of silica
interact with specific phospholipid headgroups causing change in lipid order that lead to membrane
damage and LMP resulting in initiating inflammatory events in macrophages, three model systems
were used in order to better understand the relative bioactivity among a group of silicates. These
model systems were human RBC, BMdM, and liposomes. Human RBC were used to simulate the
lysis of a complex membrane which includes proteins, that have been shown to correlate with
ability of particles to induce LMP in macrophages [15,22,25,26,33]. BMdM were used as a model
for how alveolar macrophages may respond to inhaled silicates in humans. Finally, liposomes were
used for the purpose of determining interactions and the resulting changes to the membrane in
terms of lipid order. Liposomes lack the complexity of mammalian lysosomes but are controllable
in their composition, which allows for easy probing of the membrane in experiments that would
be very difficult to conduct within macrophage lysosomes.

All materials tested in this study have been described to contain NFS on their surface except for
the gQ and gQ-f (10.7) particles. The results demonstrated that NFS on the surface of these silicates
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directly related to their hemolytic activity (Figure 1). Previous studies have reported on the lack of
toxicity of amorphous silica compared to crystalline silica which would be best explained by
differences in surface properties [25,34,35]. Formation/presence of NFS on cut or milled silicates
provides an explanation for the increased hemolysis when compared to spherical, amorphous
silica. Furthermore, this concept of critical surface properties may relate to blood compatibility or
hemolysis caused by various engineered nano-materials (ENM) [36–39]. Functional groups on the
surface of ENM similar to NFS may explain their lytic properties.

Dose-dependent toxicity and IL-1ß release were observed when BMdM were treated with NFScontaining silicates. Our laboratory among others, has observed that min-u-sil-5 caused LMP in
macrophages with subsequent IL-1ß release [14,15,40,41]. While LMP wasn’t measured in this
current study, cell death and cytokine release are two events that are downstream of LMP and
NLRP3 inflammasome formation. Therefore, LMP is likely occurring with silicate-treatment and
is predicated upon the presence of NFS on the material. In vitro experiments with macrophages
aid in predicting in vivo toxicity and inflammation, however, they are not always sufficient in
resolving the mechanisms and physical properties underlying toxicity and ability to cause
inflammation in vivo.

Liposome model systems have been previously used to measure ENM and silica adsorption, lysis,
and changes to membrane order [29,42,43]. In this study, liposomes were treated with various
silicates and analyzed for changes to lipid order, which were predicted if an interaction occurs
between the material and phospholipid membrane. This may be similar to what happens in the
phagolysosomes of macrophages prior to LMP. Also, a change to membrane properties, such as
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lipid order, may be necessary before leakage of proteases from the lysosome. All silicates that
produced a change to lipid order did so to DOPC liposomes, but not DOPS liposomes. The main
difference between the two lipids is the presence of a carboxylic acid on the DOPS headgroup,
where DOPC only has an amine. This gives the DOPS liposomes a negative charge that likely
repels the negative charge from the NFS on the surface. One inconsistent result was that gQ-f
(10.7) which does not have NFS did produced a significant change to 100-nm liposomes, however
predicted results were obtained with 500-nm liposomes. This indicates that the size of the material
in relation to the liposome is important and that the curvature of the membrane may play a role in
facilitation the interaction and ensuing permeability. In this scenario, 500-nm liposomes would not
facilitate as much of an interaction between surface NFS and the phospholipid headgroups. A
potential interaction could be between surface NFS and the phosphate groups of lipids. Further
work will be required to determine the physical changes in the interaction between NFS on silicates
and specific phospholipids in membranes.

Conclusion

It is important to consider specific surface properties when examining the membranolytic
capabilities of particulates. The silicates tested in this study all have a similar composition,
however, differences in preparation or manufacturing have slightly changed the grouping of
silanols on the surface to form NFS. This subtle change influences the ability of these materials to
interact with and permeabilize membranes. In order to fully understand the mechanisms of LMP
and particle-induced inflammation, interactions at the molecular level need to be elucidated. These
mechanisms allow for better prediction of which silicates are more bioactive and which workplace
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environments might produce the more dangerous materials. Future work will have to be done to
further clarify the role of membrane size and curvature on silica-induced lysis. Furthermore,
improved lysosomal models will aid in better translating the observed molecular events to alveolar
macrophages. Silica-induced LMP may have similar mechanisms to that of other materials that
cause membrane lysis, a better understanding of which may help develop treatments and
therapeutics for chronic inflammatory diseases.
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Abstract

Engineered nano-materials (ENM) are widely used in everyday products leading to an increased
concern for human exposure. Because of the size of ENM, they can be easily aerosolized and
inhaled, depositing in alveoli of the lungs. Alveolar macrophages, which are the primary immune
cell in that part of the lungs, phagocytose ENM, which can initiate phagolysosomal membrane
permeability (LMP) leading to NLRP3 inflammasome assembly and trigger the release of IL-1ß
and IL-18. In this study, macrophage-like THP-1 cells stably expressing YFP tagged ASC were
used as a macrophage model for quantitative NLRP3 inflammasome formation. Titanium dioxide
(TiO2) and zinc oxide (ZnO) ENM were chosen for this study because they are some of the most
commonly used ENM, along with being similar in type and size, 24 nm and 20 nm, respectively.
THP-1 YFP-ASC cells were treated with either TiO2 or ZnO ENM at various doses for 4 or 24
hours. NLRP3 inflammasome formation as a measure of LMP was analyzed by detecting YFPASC speck formation. Both ENM induced a moderate increase in speck formation at 4 hours with
a much larger increase caused by ZnO at 24 hours. In order to investigate if the two ENM induced
pyroptosis as a result of NLRP3 inflammasome activation, western blots of THP-1 cells treated
with TiO2 or ZnO for 24 hours were performed to observe formation of the P30 fragment of
Gasdermin D, which has been reported to cause pore formation in the plasma membrane. ZnO
produced more Gasdermin D activation compared to TiO2. Taken together, these results
demonstrate a quantitative approach for measuring NLRP3 inflammasome activation in response
to ENM treatment and the relationship between NLRP3 inflammasome formation and Gasdermin
D activation.
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Introduction

Engineered nano-materials (ENM) encompasses a broad category of materials that have one
dimension less than 100-nm. Because of this comprehensive classification, there are almost
limitless varieties of ENM. In recent years, the numbers of ENM generated, as well as their uses
are expanding [1]. Many of these ENM are utilized in everyday consumer products and with this
growth comes more concern for human exposure to these advanced materials. Many ENM are
handled in a fine powder form, so there is concern for aerosolization and inhalation of these
materials [2,3]. Because of their exceptionally small size, ENM can deposit in the alveolar space
of the lungs. After deposition, alveolar macrophages will encounter the ENM and phagocytose
them [4–6]. This process can result in inflammation by the release of IL-1ß and IL-18, which have
been implicated in chronic inflammatory diseases [7–9]. The factors determining the strength of
the inflammatory response are molecular events that occur in the macrophage after phagocytosis.
It has been proposed that phagolysosomal membrane permeability (LMP) is a key step in this
inflammatory pathway. LMP occurs after phagocytosis and stripping of the protein corona in the
acidic environment of the lysosome [10–12]. Normally phagocytosed material is degraded in the
acidic and proteolytic environment of the phagolysosome, but ENM are not broken down very
well, if at all [4-6]. Leakage of the lysosomal contents into the cytosol can result in the assembly
of the NLRP3 inflammasome. When the NLRP3 protein senses cellular stress or damage, it begins
to oligomerize and recruit the adaptor protein, ASC, which in turn recruits procaspase-1 to the
protein complex [13–19]. From here, procaspse-1 undergoes self-cleavage, which functions to
process pro-IL-1ß and pro-IL-18 to their active forms [13–19]. Thus, an understanding of LMP
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and the formation of the inflammasome can be informative for resolving discrepancies in
bioactivity between similar ENM.

Cells expressing fluorescently tagged components of the NLRP3 inflammasome have been used
in the past to detect and quantify formation of this protein complex. Macrophage-like THP-1 cells
stably expressing YFP-tagged ASC have been to measure NLRP3 inflammasome formation in
response to viral or bacterial pathogens [20–22]. Formation of the inflammasome causes
oligomerization of ASC and results in a bright fluorescent speck within the cell. Consequently,
NRLP3 inflammasome assembly can be quantitated and evaluated with respect to upstream or
downstream events.

Two relevant ENM were chosen for investigation in this study, which were titanium dioxide (TiO2)
and zinc oxide (ZnO). These two materials were selected because they are of similar type
(spheroid) and size, with TiO2 being 24-nm and ZnO at 20-nm. Both TiO2 and ZnO are used in a
variety of products such as sunscreens and cosmetics [23–25]. Generally ZnO is considered to be
a more bioactive material in macrophages than TiO2 [25]. THP-1 YFP-ASC cells were stimulated
to become macrophage-like phagocytes and were treated with either TiO2 or ZnO. These
treatments were performed for 4 or 24 hours. The potassium ionophore, nigericin, was used as a
positive control for NRLP3 inflammasome formation [26–28]. Furthermore, the ability of each
ENM to induce pyroptosis was also examined by Gasdermin D cleavage to form the P30 fragment
of Gasdermin D.
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Materials and Methods

Cell Lines and Reagents

THP-1 cells stably expressing YFP tagged ASC were a generous gift from Dr. Mikhail Gavrilin.
These cells were generated as previously described [20–22]. Standard THP-1 cells were purchased
from ATCC (cat# TIB-202, Manassas, VA). Titanium dioxide P25 ENM were from Evonik
(Parsippany, NJ) and zinc oxide ENM were from Meliorum Technologies Inc. (Rochester, NY).
The growth media was HEPES-buffered RPMI 1640 supplemented with L-glutamine (10-041-CV
Corning, NY). This was enriched with heat inactivated fetal bovine serum (35-016-CV, Corning)
to a final concentration of 10%. Beta mercaptoethanol was added at a concentration of 0.05 mM.
Penicillin-Streptomycin was added at 1% (100U/ml) along with 1mM sodium pyruvate (30-002CI and 25-000-CI, Corning). Complete growth media was filter sterilized before use. Vitamin D₃,
1α, 25-Dihydroxy was purchased from Millipore (679101, St. Louis, MO). Phorbol, 12-myristate,
13-acetate (PMA) was from Sigma-Aldrich (P8139, St. Louis, MO). Lipopolysaccharide (LPS)
from E. coli was acquired from Sigma Aldrich (L4516). For cell culture, 8-well chamber slides
with glass bottoms were from Thermo-Fisher (155409, Waltham, MA). Six well cell culture plates
were acquired from Corning (3516). The cell titer 96 one step MTS assay was from Promega
(G3582, Madison, WI).
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Differentiation of THP-1 Cells and ENM Exposure

THP-1 YFP-ASC or THP-1 cells were differentiated to become macrophage-like cells. Vitamin
D3 was added to the cells at 150 nM, and the cells were incubated at 37°C overnight. After cells
became semi-adherent, they were scraped and counted before seeding in the appropriate culture
vessel at 1x106 cells per ml. LPS was added at 1 ng/ml, while PMA was also added at a final
concentration of 10 nM. For 24-hour ENM exposures, either TiO2 or ZnO were added at
appropriate doses right after addition of LPS and PMA. ENM particles were prepared in stock
solutions of complete growth media at 1 mg/ml and were sonicated in a Qsonica (Newtown, CT)
Q500 sonicator for 2 minutes. The cells were then incubated at 37°C for 24 hours. For shorter (4
hour) exposures the cells were incubated with appropriate concentrations of PMA and LPS
overnight, prior to ENM treatment. Treated cells were used for imaging, MTS assays, or western
blots.

Western Blots
Cells were washed once with PBS and lysed with RIPA buffer containing HALT protease
inhibitors from Thermo-Fisher (78429, St. Louis, MO). The lysates were run on NuPAGE 412% Bis-Tris 1.0 mm polyacrylamide gels from Thermo-Fisher (NP0321PK2). The western
blot primary antibody for Gasdermin D was purchased from Sigma-Aldrich (G7422,). The ß-actin
primary antibody for western blotting was from Cell Signaling Technology (4967, Danvers, MA).
An HRP conjugated donkey anti-rabbit IgG secondary antibody was used for both Gasdermin D
and ß-actin, which was purchased from BioLegend (4064, San Diego, CA).
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Cell Imaging and ASC speck Quantification

After treatment, THP-1 YFP-ASC cells were washed once in 8-well chamber slides with PBS and
incubated with HCS nuclear mask blue at 37°C for 30 minutes. The staining solution was then
washed once with PBS. Next, the cells were imaged on a ThorLabs (Newton, NJ) iCys laser
scanning cytometer with 60X objective. A 405 nm laser was used to excite the nuclear stain with
emission captured through a 440/30 nm bandpass filter. The YFP-ASC was excited with a 561 nm
laser, and emission captured with a 550/30 nm bandpass filter. In order to quantitate ASC speck
formation in the cells, gates were set to determine cells that contained one ASC speck within them.
Size and intensity thresholds for nuclei and ASC specks were determined experimentally. Cell
nuclei in the blue channel were gated on an intensity threshold of 1627 AU and a size threshold of
at least 20 µm2. The cells containing one nucleus above the size and intensity thresholds, were
further gated to determine ASC speck positive cells. ASC specks in the yellow channel were
contoured on an intensity threshold of 16151 AU and a size threshold of below 20 µm2. Cells
containing one nucleus and one ASC speck were counted as speck positive cells. At least 500 cells
per condition were scanned on the iCys. The number of speck positive cells were divided by the
total cells counted to generate a percentage.

Statistical Analysis
When comparing more than two means, a one-way ANOVA was used with a Dunnett post-test for
comparison of each experimental mean to that of the control. For comparison of two means, an
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unpaired t-test was used. All tests were two-tailed, and statistical significance was determined by
a p-value < 0.05. Graphpad (San Diego, CA) Prism 7 was used to perform the statistical analysis.

Results
For the purpose of assessing the ability of TiO2 or ZnO to induce NLRP3 inflammasome
formation, THP-1 YFP-ASC cells were treated at various doses of the ENM for 4 or 24 hours.
After ENM treatment, NLRP3 inflammasome formation was monitored on an iCys laser scanning
cytometer by imaging bright fluorescent YFP-ASC specks in the cells. In order to validate ASC
speck formation in the cells, a positive control was used, which was the potassium ionophore
nigericin. Nigericin has been reported to cause potassium efflux, which causes ASC
oligomerization and NLRP3 inflammasome formation, thereby producing a fluorescent speck in
the THP-1 YFP-ASC cells [21,28]. Figure 1 displays images of THP-1 YFP-ASC cells treated
with 10 µM nigericin for 4 hours. Treatment with nigericin caused the diffuse YFP fluorescence
in the cytosol to form punctate specks, indicating assembly of the NLRP3 inflammasome. Images
of nigericin-treated cells were used for determining size and intensity thresholds, in order to
properly contour the ASC specks in the cells and calculate the percentage of cells that were speck
positive.
Control

10 µM Nigericin

Figure 1: Images of THP-1YFP-ASC Cells Treated With Nigericin for 4 Hours. Representative
images of control cells and cells treated with Nigericin for 4 hours at 10 µM are shown. Blue
fluorescence indicates nuclear staining, while yellow fluorescence indicates YFP-ASC.
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Representative images of THP-1 YFP-ASC cells treated with either no ENM or 100 µg/ml of TiO2
are shown in Figure 2 with control cells in A and TiO2 treated cells in B. Some speck formation
can be seen in the cells treated with TiO2, however, the condensation of the diffuse YFP
fluorescence in the cytosol is moderate compared to that of the nigericin-treated cells.
Quantification of ASC speck formation is shown in Figure 2C, in which treatment with 100 µg/ml
of TiO2 caused a moderate, but significant increase in speck formation at 4 hours. These results
demonstrate that TiO2 can cause some NLRP3 inflammasome formation, which is downstream of
LMP and is thought to be a predictor of the relative bioactivity of individual ENM in macrophages.
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Figure 2: Treatment of THP-1 YFP-ASC Cells with TiO2 for 4 Hours. Control cells are
displayed in panel A, while cells treated with 100 µg/ml TiO2 are shown in panel B. Images
are representative of three experimental replicates. Blue fluorescence indicates nuclear
staining, while yellow fluorescence indicates YFP-ASC. Panel C shows quantification of
speck formation in these cells. At least 500 cells were scanned for each condition. The
asterisk denotes p < 0.05. n = 3
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Figure 3: Treatment of THP-1 YFP-ASC Cells with ZnO for 4 Hours. Control cells are
displayed in panel A, while cells treated with 50 µg/ml ZnO are shown in panel B. Images
are representative of three experimental replicates. Blue fluorescence indicates nuclear
staining, while yellow fluorescence indicates YFP-ASC. Panel C shows quantification of
speck formation in these cells. At least 500 cells were scanned for each condition. The asterisk
denotes p < 0.05. n = 3

Next, the cells were treated with ZnO at doses ranging from 12.5-50 µg/ml. Images of control cells
compared to cells treated with 50 µg/ml of ZnO are displayed in Figure 3. Similar to the results of
TiO2 treatment, ZnO caused moderate speck formation in the cells with some condensation of the
diffuse cytosolic YFP fluorescence into NLRP3 inflammasome specks, as shown in panel B.
Quantification of cells treated with 12.5-50 µg/ml of ZnO at 4 hours is shown in Figure 3C. At the
highest dose of ZnO, a statistically significant increase in speck formation was achieved. Notably,
this increase in speck formation was associated with a dose that is half of the weight/volume dose
of TiO2 that also caused a significant increase in inflammasome formation. This is consistent with
the notion that ZnO is a more bioactive and potent inducer of LMP and NLRP3 inflammasome
formation than TiO2 [19,25,29].
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Since NLRP3 inflammasome formation is downstream of LMP, treatments were done at a longer
timepoint (24 hours) in order to determine if NLRP3 inflammasome speck formation increased
with time. Exposure of 100 µg/ml TiO2 on THP-1 YFP-ASC cells for 24 hours is shown in Figure
4. The images in Figure 4 resemble those of Figure 2. There is distinguishable speck formation,
however, it was not markedly increased when compared to the 4-hour timepoint.
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Figure 4: Treatment of THP-1 YFP-ASC Cells with TiO2 for 24 Hours. Control cells are
displayed in panel A, while cells treated with 100 µg/ml TiO2 are shown in panel B. Images
are representative of three experimental replicates. Blue fluorescence indicates nuclear
staining, while yellow fluorescence indicates YFP-ASC. Panel C shows quantification of
speck formation in these cells. At least 500 cells were scanned for each condition. The
asterisk denotes p < 0.05. n = 3

The speck quantification data in Figure 4 (panel C) further illustrates this point with increased
speck formation at the highest dose of 100 µg/ml. Due to variance in the data, statistical
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significance was not achieved, however, the level of speck formation was similar to that of the 4hour timepoint. In contrast, exposure of ZnO for 24 hours yielded markedly different results.
Images of the cells treated with ZnO for 24 hours are shown in Figure 5. Cells treated with 50
µg/ml of ZnO in panel B have greatly induced speck formation with little diffuse yellow
fluorescence, displaying oligomerization of ASC. It is also notable that the blue fluorescence of
the nuclear stain appears to be shrinking in size with notable cell death as a result of the exposure.
The quantification of these images in panel C shows that there was a significant increase in speck
formation at both of the 25 and 50 µg/ml doses. This result illustrates that NLRP3 inflammasome
formation as a result of ZnO exposure increased at the 24-hour timepoint, while that of TiO2 did
not.
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Figure 5: Treatment of THP-1 YFP-ASC Cells with ZnO for 24 Hours.
Control cells are displayed in panel A, while cells treated with 50 µg/ml
ZnO are shown in panel B. Images are representative of three
experimental replicates. Blue fluorescence indicates nuclear staining,
while yellow fluorescence indicates YFP-ASC. Panel C shows
quantification of speck formation in these cells. At least 500 cells were
scanned for each condition. The asterisk denotes p < 0.05. n = 3
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Next, the ability of each ENM to cause cytotoxicity in THP-1 cells was investigated with an MTS
assay. The results of the MTS assays are displayed in Figure 6. Treatment of THP-1 cells with
TiO2 did not cause a significant reduction to cell viability, while the 25 and 50 µg/ml doses of ZnO
caused a decrease in cell viability with the 50 µg/ml dose causing a significant decrease. This is
congruent with the images of the ZnO-treated cells shown above. There appears to be cell death
with a high portion of cells imaged at the aforementioned doses of ZnO, with most of the still
viable cells containing an NLRP3 inflammasome.

Figure 6: Cell Viability of THP-1 Cells Measured by an MTS Assay. THP-1 cells were
treated with either TiO2 or ZnO at various dose for 24 hours. Data is expressed as viability
compared to control cells. The asterisk denotes p < 0.05. n = 3
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Because NLRP3 inflammasome activation has been linked to procaspase-1 activation and
pyroptotic cell death, the ability of ENM to cause pyroptosis in THP-1 cells was investigated. In
particular, Gasdermin D has been implicated in becoming cleaved by caspase-1, which in turn
allows Gasdermin D fragments to insert and aggregate, forming pores in the plasma membrane,
which may be involved in cytokine release and an endpoint for an ENM-induced inflammatory
pathway in macrophages[30–32]. The presence of cleaved Gasdermin D in ENM-treated THP-1
cells was analyzed by western blot. Figure 7 shows representative western blots of THP-1 cells
treated with either TiO2 or ZnO at the two highest doses tested for each at a 24-hour timepoint.
Treatment with ZnO caused a small increase in the presence of the P30 fragment of Gasdermin D,
which correlates with the n-terminal fragment that is the result of proteolytic cleavage. This is the
protein fragment implicated in membrane pore formation [33–35]. In contrast to ZnO, treatment
with TiO2 did not produce a change in the level of cleaved Gasdermin D. Quantification of the
protein levels from the western blots are shown in Figure 8, which are normalized to ß-actin levels
in the cells. Treatment with ZnO showed an increase in P30, but did not reach statistical
significance. This indicates that there is some Gasdermin D activity in response to ZnO treatment,
which is the ENM that caused more NLRP3 inflammasome formation than TiO2. This further
illustrates that ZnO is the more bioactive of the two ENM studied, which is indicative of its ability
to cause LMP and NLRP3 inflammasome activation, which are two of the key steps preceding cell
death and cytokine release.
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Figure 7: Western Blot Images of THP-1 Cells Treated with Either ZnO or TiO2 for 24 hours. These
are representative images of three experiments.

Figure 8: Normalized Protein Levels From THP-1 Cells Treated with ZnO or TiO2 for
24 hours. Protein levels of the P30 subunit of Gasdermin D were normalized to ß-actin
levels. n=3
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Discussion

With the increasing use of ENM and other advanced materials there is a growing need to better
understand potential adverse effects and develop improved procedures to predict potential toxicity
to achieve safer by design materials for everyday use. This can best be achieved by knowing
mechanisms of toxicity/inflammation in vivo and utilizing appropriate in vitro screening tools.
While there may be different mechanisms involved for different classes of ENM and advanced
materials, there appears to be some key commonalities for most materials that cause adverse
effects, at least in animal models. Based on extensive studies from many laboratories including
our own, some key events are the ability of “bioactive” materials to cause lysosome
permeabilization or LMP following phagocytosis of the materials that leads to assembly and
activation of the NLRP3 inflammasome [19,36–39]. However, some of the downstream events
remain less certain including mechanisms of toxicity and release of NLRP3 inflammasomederived cytokines, viz., IL-1ß and IL-18.

In this study, a novel assay to quantitate NLRP3 inflammasome formation and two downstream
events, toxicity and Gasdermin D activation, were examined in a macrophage-like THP-1 cell
model. THP-1 cells with a YFP-tagged ASC (a component of the NLRP3 inflammasome complex)
were used to visualize and quantitate the formation of the assembled NRLP3 inflammasome as an
ASC speck within individual cells. ASC speck formation was measured at two-different
timepoints, 4 hours and 24 hours. Moderate speck formation was present at the 4 hour timepoint,
which is consistent from another study, which detected ZnO-induced LMP at 4 hours [36]. This
same study also detected that lysosomal membrane hyperpolarization was caused by ZnO within
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1 hour after treatment, supporting the hypothesis that ENM cause lysosomal membrane disruption,
which leads to LMP and eventually NLRP3 inflammasome formation. In contrast, TiO2 caused
less lysosomal membrane hyperpolarization, LMP and ASC speck formation. In our work,
inflammasome formation was seen to significantly increase at 24 hours following ZnO treatment
(from ~12% to ~45%), indicating that as LMP progresses, so will inflammasome formation, along
with eventual cell death. ASC speck formation as a result of TiO2 treatment stayed approximately
the same when the incubation time was increased from 4 hours to 24 hours, indicating minimal
LMP and downstream events caused by this material. It is important to note that the dose range of
ZnO used (12.5-50 µg/ml) was half that of TiO2 (25-100 µg/ml), further showing the disparity
between the two materials’ ability to cause toxicity in macrophages. ZnO treatment caused
significantly decreased cell viability after 24 hours, while TiO2 did not. The high cell death caused
by ZnO may have contributed to the high speck formation in cells imaged at 24 hours because of
overall decreased cell numbers, which is why doses beyond 50 µg/ml of ZnO were not used.

There is increasing evidence in the literature that particles including ENM cause IL-1ß release,
which can be mitigated by use of lysosomotropic agents or drugs to modify lysosome stability. For
example, work has been previously done with cationic amphiphilic drugs (CAD) such as
imipramine, which accumulate in the lysosome and decrease LMP [40]. Imipramine treatment of
macrophages reduced cytotoxicity and IL-1ß release from silica-treated macrophages in vitro, as
well as, decreased inflammatory effects of silicosis in vivo [41]. It is possible that the mechanism
of CAD activity, through an increase lysosomal cholesterol content, acts to reduce LMP. Increased
lysosomal cholesterol content has been observed to mitigate cell death caused by lysosomotropic
detergents or reactive oxygen species-induced LMP [42–44]. The THP-1 YFP-ASC model may
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be used in order to determine the ability of different CADs to reduce LMP and inflammasome
formation.

The NLRP3 inflammasome functions to turn procaspase-1 into active caspase-1. In addition to
cleaving pro-forms of IL-1ß and IL-18, caspase-1 has been reported to cleave Gasdermin D, which
can cause pyroptosis. Since the 24 hour incubation time produced the most inflammasome
formation as determined by ASC speck formation, western blots for Gasdermin D were performed
at 24 hours on THP-1 cells treated with the two highest doses of either ENM. Exposure to 50 µg/ml
of ZnO produced an increase in the P30 fragment of Gasdermin D, which is the portion of the
protein responsible for the plasma membrane pore that is a hallmark of pyroptosis [33–35]. TiO2
exposure did not produce as much of a change in Gasdermin D P30, which is consistent with the
fact that this ENM also did not produce extensive NLRP3 inflammasome formation. Therefore,
TiO2 was not be expected to cause much, if any pyroptosis. Even though other studies have linked
caspase-1 activation and Gasdermin D P30 fragment formation to pyroptosis, it was difficult to
confirm that the ZnO-treated THP-1 cells were undergoing cell death by pyroptosis. Cells
undergoing pyroptosis are expected to swell, whereas the THP-1 cells appeared to shrink and
undergo nuclear condensation (Figure 5) as would be expected to occur in apoptosis. It could be
possible that other consequences of LMP, such as mitochondrial damage have triggered apoptosis.
The timeframe of ENM-induced inflammasome formation and cell death appeared to start at
approximately the 4-hour timepoint, which is consistent with LMP preceding NLRP3
inflammasome formation, which was seen in another study at the 4 hour timepoint [29] . The more
potent of the two materials, ZnO, continued to cause increased inflammasome formation up to 24
hours and causing significant cell death at this timepoint. Modest Gasdermin D cleavage was seen
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in ZnO-treated cells, indicating the potential for ZnO-induced pyroptosis, although as stated above
the cellular appearance was more consistent with apoptosis. Gasdermin D pore formation has been
implicated in cell death and cytokine release, and chemically blocking this pore formation has been
shown to reduce cell death [45]. Blocking of Gasdermin D pore formation could be useful in future
work with ENM, in order to determine the actual mechanism of cell death and as a means for
potentially rescuing cells and reducing inflammation.

Conclusion

Two ENM which are similar in size and type (metal oxide) were tested in this study, however, they
have differing levels of bioactivity in macrophages. This supports the idea that when assessing the
health hazard and toxicity of ENM, the molecular mechanisms that are upstream of cytokine
release, such as LMP, are important in determining the bioactivity in macrophages. Future work
which examines the ability to modify or block LMP or NLRP3 inflammasome formation in ENMtreated cells will aid in the development of safe by design ENM and therapeutic treatments.
Furthermore, these studies may elucidate evidence for why some ENM cause more LMP than
others. Modulation of Gasdermin D activity could provide another avenue for therapeutic
intervention. Selectively blocking Gasdermin D activity could reduce ENM induced cytotoxicity
and cytokine release.
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Chapter 6
Discussion
The research presented here aimed to better understand mechanisms of ENM and particulateinduced inflammation. Since LMP in alveolar macrophages is proposed to be a key step in
triggering inflammation, this molecular event was examined in this work. There are a wide variety
of different ENM that have varying levels of LMP and bioactivity. Therefore, in order to better
design ENM that are safer to work with, as well as develop therapeutics for ENM exposed people,
a molecular understanding of this process must be grasped. One of the first questions that arose
from LMP was whether bare ENM can interact with lipid membranes This was assessed by using
lipid membrane model systems, including 100-nm liposomes and human RBC, that were easily
controlled in composition. The lipophilic fluorescence probe di-4-ANEPPDHQ reported on
changes to the lipid membranes caused by ENM or silica treatment. These results indicate that
ENM and silica do act on phospholipid membranes and cause a change to lipid order. Other
publications have reported similar interactions between ENM and liposomes. In these studies, the
adsorption of ENM onto liposomes was measured and quantified, indicating an interaction
between the two [1,2]. Membrane permeability to calcein was also measured, demonstrating that
adsorption precedes leakage, which is similar to what may happen with LMP in macrophages. My
publications also reported calcein leakage from ENM treated liposomes, along with the changes
to membrane order. The measured changes to membrane order likely result from interactions
between phospholipid headgroups and the surface of ENM or silica, which occurs prior to changes
to membrane properties and leakage. Addition of cholesterol to the model liposomes attenuated
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some of the ENM-induced changes to membrane order. This is an important observation because
cholesterol has been proposed to increase order and structure in membranes. Increased lysosomal
cholesterol has been implicated in reducing LMP [3,4]. Lysosomal cholesterol levels may also
explain some discrepancies between ENM bioactivity in different in vitro models. While increased
lysosomal cholesterol has some similarities to disease stats such as Niemann-Pick Type C, it may
pose a potential target for therapeutic intervention for treating chronic inflammation in individuals
exposed to particulates. For example, inhibitors of acid sphingomyelinase (ASM) have been
reported to reduce cholesterol trafficking out of the lysosome, as an indirect effect of inhibiting
ASM [5,6]. Many of these inhibitors are already approved for use in humans as anti-depressants,
which suggests there is potential for further investigation into the use of pharmaceuticals to block
LMP.

Another conclusion was that surface charge of the head groups of the phospholipids and ENM play
a role in the interaction of the two. More negatively charged TiO2 and silica interacted more with
neutrally charged phosphatidylcholine, while the more positive ZnO acted on the negatively
charged phosphatidyl serine. Engineering of ENM with different surface charges could play a role
in reducing LMP and inflammation. Functional groups on the surface of particles can also have an
impact on membrane disruption and inflammation. When assessing toxicity of silicate materials,
nearly free silanols (NFS) were considered. These groups are spaced approximately 4-6Å apart on
the surface of silicates, and can be influenced by fracturing and heating [7]. Crystaline silica (minu-sil 5) along with fractured synthetic quartz and vitreous silica were tested on liposomes, RBC,
and macrophages. Most types of the silicates tested caused disruption to phosphatidylcholine
membranes, which are similar in charge and structure. However, these materials did not act on
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phosphatidylserine membranes, likely because of the negative surface charge of the lipids and
particles. Increased NFS on the surface of the materials caused an increase in hemolysis of RBC,
as well as cytotoxicity in macrophages and IL-1ß release. This information aids in understanding
differences in toxicity between certain silicates like crystalline silica and amorphous silica. It also
demonstrates that silcates have a similar interaction with membranes when compared to ENM, and
that this interaction could produce similar membrane changes that lead to LMP. Because of their
perceived similarities in the inflammatory pathway, therapeutic intervention in LMP may be
effective in attenuating silica or ENM-induced chronic inflammation.

With evidence provided that bare ENM interact with membranes, ZnO and TiO2 were compared
for their ability to cause LMP and inflammasome formation in macrophage-like THP-1 cells.
Based on a previous study comparing the particles, it was assumed that ZnO would be more
bioactive than TiO2 [8]. The THP-1 cells stably expressed YFP-ASC, which was used to quantitate
inflammasome formation as a fluorescent speck, which is another key step downstream of LMP.
Treatment for 4 hours with both ENM caused moderately increased speck formation with both
TiO2 and ZnO. When the treatment time was increased to 24 hours, the speck formation for both
materials increased with ZnO being much greater than TiO2. This further supports the notion that
LMP precedes inflammasome formation before cytokine release. In the studies described above,
membrane disruption was observed in a few hours for liposomes and RBC. Changes in lysosomal
membrane potential have also been observed at the 4 hour timepoint, which may be the result of
membrane disruption caused by the particles [9].
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There is more inflammasome formation at the 24 hour time point because LMP has probably
completed, allowing maximal inflammasome formation to happen. High levels of cytokine release
for ENM treated macrophages have been observed at the 24 hour timepoint [8,10]. These data
provide some explanation that TiO2 and ZnO both act on lipid membranes, but ZnO may act on
phosphatidylserine in the lysosomes of macrophages, causing more membrane disruption than
TiO2, which lead to these downstream inflammatory events described above.

As mentioned previously, macrophages undergoing LMP can eventually experience a process
called pyroptosis, which is realized by the activation of the plasma membrane pore forming
protein, GSDMD [11]. It is thought that this pore is formed downstream of LMP and that it
facilitates cytokine release and cell death. Because of this, GSDMD pore formation is arguably the
last step in this pathway to cytokine release. In THP-1 cells treated with ZnO or TiO2, GSDMD
activation by enzymatic cleavage was measured by western blot. The active P30 fragment was
seen to moderately increase with ZnO treatment but not a significant amount with TiO2 treatment
at 24 hours. It makes sense that ZnO has more GSDMD activation than TiO2 because ZnO
triggered more LMP and inflammasome activation than TiO2. The cells treated with ZnO did also
have an apoptotic appearance, so future work will need to be done in further clarifying and
determining the role of additional materials in causing pyroptosis in macrophages. Because this
step is thought to be linked to cytokine release, it could be another critical step in dictating why
some ENM or particles are more bioactive than others. Its modulation may also be able to reduce
inflammation in different models.
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